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Background and objectives: Sexually transmitted infections (STIs) have a profound impact on 
sexual and reproductive health. Despite decades of control efforts, STIs are still common in 
Australia and remain the major public health concern. This research was conducted within the 
context of increased diagnoses of STIs, control of STIs and prevention of HIV transmission in 
South Australia. The objectives of this research project were to: (1) explore and compare the 
trends in gonococcal diagnoses among heterosexuals, and investigate the plausible reasons for 
the gonorrhoea epidemic among heterosexuals; (2) examine the trends in gonorrhoea 
diagnoses among MSM and to determine whether seasonal variations in gonorrhoea diagnoses 
were evident in MSM; (3) determine the trends in HIV testing and examine factors associated 
with recent HIV testing among MSM; and (4) evaluate treatment efficacy of two treatments for 
rectal chlamydial infection, in order that future public health policy, clinical practice and future 
research are informed by the best evidence.  
Methods: The research project was a quantitative analysis of medical records using longitudinal 
clinical data. The first study was a cross-sectional and retrospective analysis to understand how 
the gonorrhoea trends observed in South Australia compare to those seen in other Australian 
state capitals, Melbourne (Victoria) and Sydney (New South Wales). Additional analyses were 
undertaken to investigate factors associated with the gonorrhoea epidemic among 
heterosexuals in Adelaide to explore whether the observations were unique or part of an 
Australia-wide phenomenon. In the second project, cross-sectional study was conducted to 
assess whether seasonal variations in urethral gonorrhoea diagnoses were evident in MSM in 
xiv 
 
three Australian states. The third study explored computerised medical records of MSM who 
attended the Adelaide Sexual Health Centre (ASHC) at their first visit between 1994 and 2015 to 
determine whether HIV testing had changed and examine factors associated with recent HIV 
testing among MSM. The fourth study was a retrospective analysis to evaluate treatment 
efficacy of two treatments for rectal chlamydial infection. 
Results: In the first study, a gonorrhoea epidemic has been identified between 2006 and 2010 
among heterosexual men, women and female sex workers (FSWs) compared with other years; 
the odds of gonorrhoea were significantly associated with FSWs in the epidemic years at ASHC. 
No corresponding trend in gonorrhoea diagnoses was seen at Melbourne Sexual Health Centre 
(MSHC) and Sydney Sexual Health Centre (SSHC). It is noted that around the same time 
convictions against FSWs peaked in Adelaide and newspaper reports of increased police activity 
against FSWs where carrying condoms had been used as evidence of sex work by police. In the 
second study, peaks of gonorrhoea cases were observed in the first quarter of the year in 
Adelaide and Sydney but in the second and fourth quarter in Melbourne. The third study 
showed the proportion of newly registered MSM who reported ever being tested for HIV 
declined; recent HIV testing did not change and current HIV testing increased between 1994 
and 2015. The proportion of MSM who returned for HIV testing within 12 months did not 
change, with less than 40% of MSM returning for HIV testing. In the last study, rectal chlamydia 
prevalence was 6.7% and 8.1% respectively in men and women. Treatment with azithromycin 
was significantly associated with 3-fold higher risk of repeat rectal chlamydial infection. The 
significant association of treatment regimen with repeat rectal chlamydia remained after 
adjusting for other factors.  
xv 
 
Conclusions: The first study suggests that increased policing against sex workers may reduce 
access to condoms, thereby increasing rates of unprotected sex. SA government should 
consider legislative revisions to stop using possession of condoms as evidence of sex work. The 
second study finds that gonorrhoea among MSM occurs in a seasonal pattern, particularly late 
summer into early autumn. This has implications for the provision of health services and 
resource allocation over the year and for the timing of health promotion activities. The third 
study highlights that HIV testing rate among MSM attending ASHC was suboptimal and new 
approaches are needed to increase the uptake and early detection of HIV infection among the 
high-priority MSM population. The last study identifies that azithromycin was associated with 
repeat rectal chlamydial infection compared to doxycycline, suggesting that doxycycline may be 
more effective than azithromycin in the treatment of rectal chlamydia infection in men and 
women. Given that STIs remain a neglected area of research and many countries observed 
simultaneous increases of HIV and STIs today including Australia, especially among men who 
have sex with men (MSM), the findings from this research project have implications for sexual 
health policy, clinical practice and future research in this area. 
 
Key words: Sexually transmitted infections, epidemiology, men who have sex with men, 
heterosexuals, gonorrhoea, rectal chlamydia, HIV testing, azithromycin, doxycycline, treatment, 








The human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) constitute 
the most common public health problem throughout the world and represent a huge burden in 
both mortality and morbidity, causing detrimental health effects 1-3. Despite decades of global 
control effort has been made to reduce their high global incidence and prevalence, STIs other 
than HIV have been neglected as a public health priority 4,5. Control efforts continue to fail and 
simultaneous increases of HIV and STIs notifications have been observed in many countries 
including Australia, especially among men who have sex with men (MSM) 3. Globally, MSM are 
disproportionately burdened by HIV and other STIs. The reasons for the disproportionate 
infection burden among MSM are complex; In addition to biological and medical reasons, 
behavioural, social, political and economic factors also make great contributions 6,7. Effective 
control of STIs include basic epidemiological and surveillance data, high quality evidence about 
effectiveness of individual interventions, better methods to get effective intervention onto the 
policy agenda, and better advocacy and more commitment to get them implemented properly 
8. 
 
The World Health Organisation (WHO) estimated 36.7 million people living with HIV/AIDS 
(acquired immune deficiency syndrome), 1.8 million people became newly infected with 
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HIV and 53% of people living with HIV were receiving antiretroviral treatment worldwide in 
2016 (Figure 1.1) 9; Globally, there were 357·4 million new cases of four common curable STIs: 
chlamydia (130·9 million cases), gonorrhoea (78·3 million cases), syphilis (5·6 million cases), and 
trichomoniasis (142·6 million cases) in 2012 (Figure 1.2) 10. The estimated annual incidence of 
non-HIV STIs has increased by nearly 50% between 1995 and 2008 11. Additionally, HIV and STIs 
such as gonorrhoea, syphilis and Lymphogranuloma venereum (LGV) have re-emerged in high-
income countries 12-16; there are alarming increases in antimicrobial resistance in Neisseria 
gonorrhoeae (NG) and Mycoplasma genitalium (MG), particularly among MSM 4. Meanwhile, 
there is growing evidence that the epidemiology of HIV and STIs is changing, control efforts may 
be severely challenged once again 4. The increases in STIs and HIV have been caused by a 
combination of factors: lack of accurate, inexpensive diagnostic tests, particularly for chlamydia 
and gonorrhoea; insufficient resources to strength healthcare systems that can deliver 
necessary services for diagnosis and management of STIs; inefficient of surveillance and disease 
notification systems in many countries; political, socioeconomic and cultural barriers that limit 
recognition of STIs as an important public health problem; and failure to implement policies 
that are known to work 11. 
 
In Australia, the notifications of sexually transmissible infections (STIs) are on the rise including 
gonorrhoea, chlamydia and syphilis. The recent Annual Surveillance Report from Kirby Institute, 
the University of New South Wales (UNSW) showed that there has been a 63 per cent increase 
of gonorrhoea in Australia over the last five years, with 23,000 people diagnosed in 2016 alone. 
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Gonorrhoea notification rates have nearly tripled from 35.6 per 100,000 in 2004 to 100.8 per 
100,000 in 2016 and similar trends were observed in South Australia 17,18. Chlamydia was still 
reported as the most commonly diagnosed STI in Australia, with an estimated 154,000 men and 
100,000 women aged between 15 and 29 with new chlamydia infections in 2016. The 
notifications for infectious syphilis increased from 6.9 per 100,000 in 2012 to 14.3 per 100,000 
in 2016. There were over 3000 new reports of infectious syphilis in 2016, with 87 percent of 
them in males. Gonorrhoea occurs predominantly among gay and bisexual identified men who 
reported both male and female sexual partners whereas rates in heterosexuals are low except 
in some minority populations 19-21.  
 
The relationship between HIV and STIs is complex due to biological and behavioral factors 22. 
Studies have shown gonorrhoea, chlamydia and syphilis can increase the risk of HIV among 
MSM 23,24. HIV and STIs may interact with each other in the following ways (Figure 1.3) 25,26: 
 HIV, by causing immunosuppression, can modify the natural history (duration), clinical 
presentation (severity), and response to treatment of certain STIs, notably other viral 
infections such as genital herpes simplex virus infection or human papillomavirus. 
 STIs, by causing ulceration or inflammation of the genital tract, may enhance the 
transmission of HIV by increasing infectiousness of HIV-positive individuals and/or the 




Figure 1.1 WHO estimates of number of people (all age) living with HIV, 2016 4 
 
Figure 1.2 WHO regional estimates of new cases of four curable sexually transmitted 




Figure 1.3 Relationships between HIV and other STIs 25 
 
The importance of periodic HIV testing as a preventive strategy in the programmatic response 
to the HIV/AIDS epidemic has been highlighted at the global level, especially in 
disproportionately affected MSM population. Increasing the rates of HIV testing is supported 
across a number of strategic documents addressing HIV 27,28. In Australia, it is estimated that 
21,391 people living with diagnosed HIV infection with 80% of them attribute their infection to 
male-to-male sexual contact. The prevalence of HIV among all MSM in Australia is 
approximately 11.2% 17. A significant percentage of HIV infections are from people who do not 
know their HIV status. An estimated 31% of new HIV infections are transmitted from the 
approximately 9% of MSM with undiagnosed HIV. Rates of undiagnosed HIV among MSM have 
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been estimated between 10% and 20% in Australia 29. The average time between a person 
becoming infected with HIV and being diagnosed is estimated at approximately four year 30. 
Hence Monitoring trends and predictors of HIV testing among gay men and other MSM will 
increase the number of MSM aware of their HIV status, minimize the time between infection 
and diagnosis and treatment, and reduce further transmission. Meanwhile, increased testing 
and more people knowing their HIV status will improve health outcomes for people with HIV 
and reduce health impacts of late diagnosis. Recent research has shown large reductions in HIV 
transmission from people on effective antiretroviral treatment (ART), also known as ‘Treatment 
as prevention’ (TasP), the strategy of treating HIV-positive people with ART to prevent onward 
sexual transmission of HIV 31-33. Optimising TasP is a goal of the current national HIV strategy, 
which aims to ‘. . .work towards achieving the virtual elimination of HIV transmission in 
Australia by 2020’ and to ‘. . .increase the proportion of people living with HIV on treatments 
with an undetectable viral load’ 27. WHO has announced ambitious new HIV treatment 
guidelines which will see the number of people eligible for HIV treatment rising substantially. 
The new guidelines recommended earlier commencement of ART for people with HIV, 
increasing the treatment initiation threshold from a CD4 count of less than 350 to less than 500 
as well as recommendations for earlier commencement of treatment for people with HIV 34.  
 
Extragenital chlamydia and gonorrhoea are common and may be important reservoirs for 
ongoing STI transmission 35. They are more likely to be asymptomatic among MSM 36. MSM 
reporting unprotected receptive anal intercourse (RAI) had a high prevalence of rectal 
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gonorrhoea and rectal chlamydia. HIV-positive status was significantly associated with 
prevalent rectal chlamydia 37. However, many MSM were not tested and most extragenital 
infections would not have been identified, and remained untreated, with urethral screening 
alone, in which patients is less likely to seek medical assistance (Figure 1.4 and Figure 1.5). 
There are also increasing reports of rectal chlamydia among women coinciding with studies 
showing that anal sex among heterosexuals is more common 38. Prevalence of rectal chlamydia 
has been reported to be as high as 24.4% among MSM and 17.5% among women 39. Studies 
across 11 STI clinics demonstrated that 70% – 88% of rectal chlamydia and gonorrhoea 
infections have no concurrent urethral infection as rectal STIs among MSM 36. The use of 
nucleic acid amplification testing (NAAT) has enhanced the ability to detect frequently 
asymptomatic gonococcal and chlamydia infections of the rectum and other sites 40. The rates 
of chlamydia among MSM are relatively low in the pre-AIDS era, but the infection rates have 
now been continuously increasing among MSM over the past decade 30,41. It is possible that 
further increases in rectal chlamydia infection will occur due to the widespread uptake of 
biomedical prevention, such as pre-exposure prophylaxis (PrEP) for HIV 42. There are ongoing 
concerns about treatment failure with azithromycin for the treatment of rectal chlamydia 43,44, 
with a systematic review and meta-analysis finding that the efficacy of single-dose azithromycin 
treatment may be considerably lower than 1 week of doxycycline for treating rectal chlamydial 
infection (82.9% vs 99.6%) 45. As rectal chlamydial infection is associated with an increased risk 
of HIV seroconversion, evaluation of effective treatment for rectal chlamydial infection is 




This thesis aimed to examine the STI epidemiology at a clinic setting in Adelaide in order to 
further our understanding of STI distribution and HIV testing in the community, to explore the 
potential risk factors associated with STI epidemic by comparing the differences at three sexual 
health services, one each in Adelaide, Melbourne and Sydney; to evaluate the effectiveness of 
STI treatments in order to inform prevention efforts, to provide policy implications and 
suggestions for governments and non-government organisations (NGOs) for the effectiveness 
of prevention interventions, especially among MSM population. 
 
 





Figure 1.5 A public health perspective on STI prevention and care 47 
 
 
1.2 Aim, research questions and objectives 
 
The increased prevalence and re-emergence of STIs over the last decade necessitate renewed 
interest and awareness of STIs. The mortality and morbidity of STIs and their facilitation of new 
HIV infections are of clinical significance, which is particularly important for clinicians providing 
care to higher risk populations such as MSM. Although diagnostic and treatment options are 
fortunately well established to offer higher sensitivity, specificity and cure and may have a 
clinical impact in slowing the progression of STIs, increases in STIs have been rising at an 
alarming rate 48.  
 
The purpose of this research project was to understand how the STI trends, seasonal patterns 
and STI epidemic observed in South Australia compare to those seen in other Australian state 
10 
 
capitals: Melbourne (Victoria) and Sydney (New South Wales). Longitudinal data were used to 
determine whether there is a change in STI diagnoses, seasonal patterns, HIV testing and 
factors associated with them. Moreover, investigation was conducted to evaluate the efficacy 
of two treatments for rectal chlamydial infection at ASHC. 
 
This thesis therefore attempts to provide new and important information in relation to STI 
epidemiology, seasonal variation patterns of STI, HIV testing and treatment efficacy for STI in 
Adelaide. The specific research questions were: 
 What caused the substantial rise in diagnoses of gonorrhoea among heterosexuals 
between 2006 and 2010 in Adelaide? How did the epidemic of gonorrhoea and rates of 
diagnoses compare over time to other settings? (Chapter 3) 
 Do the seasonal patterns of STI observed in South Australia in comparison to trends in 
other Australian state capitals reveal a seasonal variation in STI among MSM? (Chapter 
4) 
 What are the trends and predictors associated with HIV testing among MSM in 
Adelaide? (Chapter 5) 
 Are the ongoing concerns about the failure of azithromycin treatment for rectal 





1.3 Thesis structure and outline 
 
This thesis has been structured into three main parts. The first part includes the introduction 
and the literature review (Chapters 1 and 2). The second part consists of four chapters 
(Chapters 3 to 6) presented in the form of published papers from studies conducted using 
quantitative research methods. Each article addresses one of the four above research 
questions. The third part is the conclusion (Chapter 7) which highlighted the key findings, 
implications, recommendations and areas for future research. The schematic diagram of the 
thesis structure is shown in Figure 1.6. 
 
I present this thesis for examination in the form of “thesis by publication”. Four studies were 
conducted for this research project. All chapters presented in this thesis have been published in 
peer-reviewed journals. The first paper was published in Sexually Transmitted Infections (STI) 
Journal. The second and third papers were both published in Sexual Health. The fourth paper 













































Epidemic of gonorrhoea among 
heterosexuals 
Chapter 4 
Gonorrhoea incidence among MSM 
Chapter 5 
HIV testing among MSM 
Chapter 6 
Treatment efficacy for rectal chlamydia 
Chapter 7 
Conclusions, implications, recommendations and future research areas 
Chapter 1 
Introduction & aim, research questions and objectives 
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Below is a brief description of contents from each chapter: 
 
Chapter 1 presents an overview of the research project by describing the research background 
and research questions. The aim, objectives and research questions of the research project are 
outlined.  
 
Chapter 2 reviews the literature on the epidemiology of the human immunodeficiency virus 
(HIV) and Sexually Transmitted Infections (STIs) among men who have sex with men (MSM). 
The aim of this chapter is to provide a comprehensive review of the literature on major STIs and 
HIV infection among MSM and to identify effective prevention intervention strategies for MSM.  
The review examined the epidemiology of STIs and HIV infection among MSM, described the 
factors associated with sexual risk in this population and provided recommendations for 
effective prevention intervention and further research to better understand the sexual risks 
among MSM in Australia and other industrialised countries.  
 
Chapter 3 investigates the substantial rise in gonorrhoea diagnoses among heterosexuals 
between 2006 and 2010 in Adelaide and to explore factors that could have influenced the 
epidemic. The Chapter addressed the research question “What caused the substantial rise in 
diagnoses of gonorrhoea among heterosexuals between 2006 and 2010 in Adelaide?” This 
study was a quantitative study with retrospective analyses of gonorrhoea diagnoses made by 
14 
 
sexual health services between 1990 and 2012 in Adelaide, with the comparison with that from 
Melbourne (Victoria) and Sydney (New South Wales). 
 
Chapter 4 is an extension of the previous study to examine the gonorrhoea incidence among 
MSM. The aim of this study was to formally test the hypothesis of seasonal variations of STI 
against data at three sexual health services, one each in Adelaide, Melbourne and Sydney. The 
data suggest that gonorrhoea among MSM occurs in a seasonal pattern, particularly late 
summer into early autumn. This has implications for the provision of health services over the 
year and for the timing of health promotion activities. The chapter addressed the research 
question two “Is there a seasonal variation in STI among MSM?”  
 
Chapter 5 presents the article to determine whether there has been a change in HIV testing 
among MSM at the Adelaide Sexual Health Centre (ASHC) over the past two decades. 
Computerised medical records of MSM who attended ASHC at their first visit between 1994 and 
2015 were used to determine whether HIV testing had changed among MSM. First HIV tests in 
each calendar year and return tests within 12 months were analysed. Factors associated with 
recent HIV testing were also explored. The chapter addressed the research question three 




 Chapter 6 compares treatment efficacy of two treatments for rectal chlamydial infection to 
provide evidence on ongoing concerns about treatment failure with azithromycin for the 
treatment of rectal chlamydia. A retrospective analysis of all patients diagnosed with rectal 
chlamydial infection between 2009 and 2015 in Adelaide, Australia was undertaken. The 
chapter addressed the research question four “Ongoing concerns about treatment failure with 
azithromycin for the treatment of rectal chlamydia, is this the case in Adelaide?” 
 
Chapter 7 summarises the key finding of this thesis, presents conclusions and 
recommendations based on research results, and provides future directions for research to 
address actions for policy makers that need to be taken for HIV and STI prevention and 
intervention, especially among MSM in Australia.  
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CHAPTER 2 LITERATURE REVIEW 
 
The human immunodeficiency virus (HIV) and Sexually Transmitted Infections (STIs) 





Globally, MSM are disproportionately burdened by HIV and other STIs. The reasons for the 
disproportionate infection burden are complex, including biological, behavioural, and 
sociocultural factors 49. 
 
Surveillance data suggest that human immunodeficiency virus (HIV) and sexually transmitted 
infections (STIs) are increasing among domestic and international populations of MSM 50-53. The 
epidemics of HIV in MSM continue to expand not only in many high income countries, including 
the USA, UK, France, Australia and the Netherlands where highly active antiretroviral therapy 
(HAART) is available, but also in low, middle income countries 51.  
 
The rates of new infection have been consistently high among young MSM. The prevalence of 
HIV among MSM was reported ranging from 3% to 25%. Prevalence and incidence rates are 
particular higher in the countries of Sub-Sahara Africa, the Caribbean, North, Central and South 
America and Eastern Asia compared to those from Europe, the Middle East, North Africa, 
Oceania and Central Asia, where the prevalence rates have been reported to be less than 10% 
54.  MSM are primarily at risk of HIV infection through unprotected anal intercourse (UAI). The 
estimated per-contact risk of acquiring HIV through receptive UAI with a known HIV-positive 
partner is 1-in-70 sexual contacts for a receptive partner (with ejaculation) and 1-in-909 for the 
insertive partner 55. 
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The acquired immune deficiency syndrome (AIDS) epidemic that started more than 30 years 
ago remains one of the greatest public health concerns worldwide. The re-emergence of HIV 
epidemic among MSM has posed a significant public health concern in different parts of the 
world including Western Europe, North America, Australia and China since the mid-1990s 50,56-
59.  MSM have increased rates of HIV infection and STIs compared with general population 6,60. 
MSM may be exposed to STIs in various ways. It is essential for clinicians to obtain a thorough 
sexual history in a culturally competent manner 7. 
 
Many governments have identified MSM population as a high-risk group in their STIs and HIV 
strategy 3 3,61. However, current prevention and treatment strategies are insufficient for the 
control of HIV epidemics 54. In contrast to the overall slow decline in new HIV infections, the 
number of people living with HIV has significantly increased globally, largely due to the 
expansion of highly active antiretroviral therapy (HAART). There is still no efficient vaccine to 
protect against HIV infection despite decades of HIV research and programmes 62. 
 
In Australia, since the beginning of national HIV surveillance, MSM have accounted for more 
than 70 % (19,855) of total positive HIV diagnoses over the period 1990-2016, and have been 
estimated to carry the greatest number of diagnosed and undiagnosed HIV infections 50. 
According to the Third National Sexually Transmissible Infections Strategy 2014-2017, 
Department of Health and Ageing (Australia Government), MSM are also targeted as the 
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priority population at high risk for STIs, including gonorrhoea, chlamydia, syphilis, and the 
human papillomavirus (HPV) 63. 
 
In order to better understand the epidemiology of HIV and STIs among MSM, as well as how 
these trends may inform public health policies, intervention programs, and community 
activities, this Chapter applies a comprehensive review and analyses of the scientific literature 
published in English on HIV and STIs (including gonorrhoea, chlamydia, infectious syphilis) in 
MSM based on multiple sources, including published findings, surveillance reports and 
prevention and interventions; to provide evidence on current epidemiologic trends relating to 
STIs/HIV among MSM; to explore the factors associated with the high rates of HIV and STIs 
among MSM; and to provide policy implications and recommendations for future endeavors 
targeting this high-risk group. These recommendations would impact all levels of government 
(nation and state wide), as well as Non-Government Organisations (NGOs). A better 
understanding of STIs and HIV epidemiology will allow implementation of more effective public 





2.3.1 Data Sources 
 
This comprehensive epidemiological review utilised a targeted literature search strategy at 
three levels. 
 
First, global prevalence and incidence estimates for HIV and STI infections in 2008 and report on 
global sexually transmitted infection surveillance by World Health Organisation (WHO) in 2015, 
which could retrieved from the WHO website; 
 
Second, incidence rate of HIV and STIs from surveillance reports in European Union (EU), the 
United States of America (USA) and Australia, which could be obtained from relevant 
government websites; 
 
Third, a comprehensive literature search of online database PubMed (2000-2017) was 
conducted to identify peer-reviewed journal articles related to epidemiology and risk factors 
associated with HIV and STIs among MSM. We selected peer-reviewed articles directly related 
to HIV and/or STI among MSM. We used a combination of Medical Subject Headings (MeSH) 
and keywords in our search strategy including using terms such as “men who have sex with 
men,” ‘‘MSM,” “homosexual,” “the human immunodeficiency virus,” “HIV,” “gonorrhoea,” 
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“neisseria gonorrhoeae,” “gonococcal infection,” “chlamydia trachomatis,” “chlamydia,” 
“syphilis,” “epidemiology,” “incidence”  and “prevalence” to identify the potential studies of 
interest in the search engine. Risk factors and preventions of HIV and STIs infections have been 
summarised. We also examined the reference lists of all identified studies to identify other 
studies. The search was limited to English language articles and published in peer-reviewed 
journals. 
 
Questions raised will be covered in the thesis and addressed in the literature review including: 
1) Comparison of STI rates between MSM and heterosexual men, 
2) Trend and variations in STI incidence among MSM, 
3) Trend and predictors of HIV testing among MSM, 




2.3.2 Definition of Men who have sex with men (MSM) 
 
Over the past three decades, HIV and STIs among MSM have emerged as a research field for 
those with an interest in sexually transmitted infections. But what is the definition of MSM? 
MSM are male persons who engage in sexual activity with other males, regardless of how they 
personally identify themselves. The term ‘MSM’ is an all-encompassing term and has been used 
to recognise that not all homosexually active men have a gay or bisexual identity. The term 
excludes men who identify as gay or bisexual, but who have never had sex with another man. 
MSM attempts to indicate the population of men, including transgender men, engaged in same-
sex sexual behaviour inclusive of sexual identity (gay, bisexual, straight, experimenting, etc.) 
and sexual desire (e.g. it includes men who experience no sexual desire for other men but who 
engage in sex with men for money or favours) 64.  The term was created in the 1990s by 
epidemiologists as a surveillance tool to better identify the route of HIV transmission and 
spread of the disease through male-male sexual activity. But, the term has been attributed to 
Glick et al., because their usage in a 1994 study solidified the concept in medical terminology 65. 
It has now become a standard term within HIV prevention work and research, encompasses 
both men who have sex with men only, and those who have sex with both men and women. 
The term represents an exposure category which refers to sexual behaviour and not a person’s 
self-identified sexual identity”. It is often used in medical literature and social research to focus 
on behavior rather than cultural or social self-identification thereby providing a clearer picture 
of HIV infection rates. That, in turns, provides us a better understanding of the implications of 
HIV prevention, including which prevention tools to use in which populations 66. 
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2.4 Epidemiology and disease burden of HIV among MSM  
 
Since the first description of Pneumocystis pneumonia in homosexual men in Los Angeles in 
1981 67 and the discovery of the pathogen of HIV which was related to gay-related immune 
deficiency (GRID), currently known as  AIDS identified in 1983 68, MSM have been 
disproportionately affected by HIV as compared to the men from the general population 69-71.  A 
meta-analysis of surveillance data in low- and middle-income countries found that MSM are 
19.3 times more likely to be HIV-infected than the general population 6. Emerging and 
consistent data highlight that the risk for HIV infection remains high among MSM and HIV 
remains a critical health issue for this subpopulation although an overall decline in HIV 
prevalence has been noted in many geographic regions 6. There has been a resurgence of HIV 
infection and increasing trend of HIV prevalence among MSM in different part of the world, 
particularly in industrialized countries 72. There were approximately 36.7 million people living 
with HIV at the end of 2016 with 1.8 million people becoming newly infected in 2016 globally. It 
is estimated that MSM are 24 times more likely to become infected with HIV than the general 
population 28.  
 
Reported HIV prevalence among MSM ranges from 0% to 32.9% and HIV incidence among MSM 
ranges from 1.2 to 14.4 per 100 person-years 71. The Joint United Nations Programme on 
HIV/AIDS (UNAIDS) estimated that men who have sex with men (MSM) accounted for about 5–
10% of the global burden of HIV, with considerable variation between countries and regions.  
MSM are a recognized high-risk group for HIV infection in Western Europe, North America, and 
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Australia, and HIV epidemics among MSM are well described in some low- and medium-income 
countries in Latin America and Asia 73. Recent studies from sub-Saharan Africa reported that 
HIV prevalence among MSM ranges from 6% to 31%. In Asia, the odds of MSM being infected 
with HIV are 18.7 times higher than in the general population; and the HIV prevalence ranges 
from 0% to 40%. In Latin America, it is estimated that half of all HIV infections in the region 
have resulted from unprotected anal intercourse between men 71. MSM account for a 
substantial proportion of HIV infections and compose a “bridging population” for transmission 
to heterosexuals  due to high frequency of reported bisexuality 1. 
 
New diagnoses among MSM are increasing in some regions, with a 17% rise in Western and 
Central Europe and a rise of 8% in North America between 2010 and 2014 52. In 2014, MSM 
accounted for 54% of new HIV infections in Western Europe, 68% in North America and 30% 
in Latin America and the Caribbean. In Jamaica, one in three men who have sex with men are 
living with HIV 74. In 2016, an estimated 2.1 million people were living with HIV in Western and 
Central Europe and North America. In the same year, there were roughly 73,000 new HIV 
infections and 18,000 people died of AIDS-related illnesses 52.  According to  the UNAIDS report, 
more than half of all new HIV infections occurred in the United States of America (USA), and 
more than a quarter occurred in six countries: France, Germany, Italy, Spain, Turkey and the 




In 2014, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and partners launched the 
90–90–90 targets; the aim was to diagnose 90% of all HIV-positive persons, provide 
antiretroviral therapy (ART) for 90% of those diagnosed, and achieve viral suppression for 90% 
of those treated by 2020 75-77.  
 
2.5 Epidemiology and disease burden of STIs among MSM 
 
STIs are defined as infections that can be transmitted during unprotected sex with an infected 
partner, including vaginal, anal and oral sex. However, STIs can also be transmitted through skin 
to skin contact, blood and tissue transfer, bodily fluids, as well as mother to child contact. There 
are a number of bacteria, viruses, parasites, and other organisms known to cause STIs. 
According to WHO report, there are more than 30 different infectious pathogens known to 
cause STIs in humans 78.  
 
STIs can be symptomatic or asymptomatic and may require complex clinical management. 
Common symptoms of STIs include discharge, dysuria, ulcers, and lumps and bumps. However, 
most of the STIs do not lead to symptomatic presentations, especially at extragenital sites 
(pharynx and rectum). Pharyngeal and rectal STIs are prone to be asymptomatic and 
particularly unrecognized and under detected. Without testing for the right microbes in 
relevant anatomical sites, infections will be missed. The seriousness and severity of STIs may 
vary; many cause only minor discomfort, while others can result in more complicated health 
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issues 79. Most common symptoms and signs of STIs, besides genitourinary manifestations, 
include anorectal pain or discomfort, anal discharge, rectal bleeding and constipation. A recent 
study has shown that specific sexual practices of MSM result in having a high prevalence of 
asymptomatic infection in particular anatomic sites and that these infections are the primary 
drivers of transmission 80. WHO has updated the STI syndromic management guidelines, which 
will include a management algorithm for anorectal infections in 2011 71. 
 
MSM are considered as a high-risk group for HIV infection and STIs in many countries. 
According to epidemiological data, MSM are more frequently diagnosed with STIs compared to 
general population and continue to experience disproportionately high prevalence of STIs 
including gonorrhoea, chlamydia, and infectious syphilis and HIV worldwide 6,81. According to 
WHO report, incidence of STIs disproportionately affected racial and ethnic minority MSM, 
MSM of lower socioeconomic status, and young MSM. These STIs are being diagnosed in MSM 
with and without HIV infection in the context of changing patterns of sexual behaviour 78.  
 
There is a high prevalence and incidence of almost all STIs in MSM, which is a significant cause 
of preventable morbidity worldwide and become a major public health concern among MSM. 
Elevated burden of STIs is of concern because it may indicate high risk for subsequent HIV 
infection. In Australia, more than 80% of newly acquired HIV and greater than 90% of syphilis 
and gonorrhoea diagnosed in major cities and regional areas are among MSM population 82. 
There is a strong correlation between the spread of conventional bacterial and viral STIs and 
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the transmission of HIV and associated with severe disease 83. Several studies have shown that 
both ulcerative and non-ulcerative STIs have been found to facilitate HIV transmission 24,84-86. 
Treatment for some STIs, especially gonorrhoea, has been compromised by antimicrobial drug 
resistance 87-89.  Many new STIs are elevating among young MSM. However, a substantial 
burden of HIV and STI morbidity continued to occur among middle-aged and older men 90.   
 
Since the publication of the WHO Guidelines for the Management of Sexually Transmitted 
Infections in 2004, the prevalence and incidence of STIs in MSM have continued to increase in 
the world. STI incidence among MSM may also be an indicator of higher risk for subsequent HIV 
infection 91.  Many countries have established the STI surveillance system to monitor STIs with a 
high burden, detect outbreaks and monitor progress towards national or international control 
targets. WHO/UNAIDS has published the second generation surveillance systems including 
HIV/STI and information on risk behaviours in order to warn of or explain changes in levels of 
infection in 2013 92. Surveillance of STIs is important to assess the disease burden in the 
population, to monitor and evaluate changes in trends over time. 
 
The relatively high prevalence and incidence of STI infection among MSM may be related to 
multiple factors, including individual behaviours, sexual network characteristics and 
socioeconomic factors. Individual behaviours include number of lifetime or recent sex partners, 
rate of sex partner exchange, frequent penetrative and receptive sex, frequency of unprotected 
sex and use of disinhibiting substances, including alcohol, crystal methamphetamine, and other 
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recreational drugs use during sex (Chemsex), which will influence individual’s probability of 
exposure to STIs. Sexual networks include high prevalence of STIs, interconnectedness and 
concurrency of sex partners and these will affect individual’s risk of acquiring an STI. 
Socioeconomic factors include ignorance and myths exist around male-male sexual contact, loss 
of fear regarding HIV transmission in the era of widespread uptake of biomedical prevention, 
such as PrEP for HIV, the use of Internet or dating App as an efficient way to find sex partners 
and experiences of stigma and criminalization of homosexuality, which are associated with 
increased sexual risk behavior among MSM 93. 
 
Sustained transmission of gonorrhoea and syphilis is a marker of high risk sexual activity and 
the relative burden of these infections is particularly high among MSM 94. In order to reduce 
STIs in MSM, many countries have established STI testing guidelines 95-97. The current Australian 
STI guideline recommends STI screening at least once a year, and up to 4 times a year for MSM 
who are at high risk for STIs. (e.g., MSM who have engaged in any unprotected anal sex, have 
had more than 10 sexual partners in previous six months, have participated in group sex or 
used recreational drugs during sex, or are HIV-positive) 95. 
 
Increases in STIs among MSM may also be partly explained by increased detection screening 
policies for asymptomatic MSM at extragenital sites using highly sensitive nucleic acid 
amplication tests. Increasing resistance and decreased susceptibility to antimicrobials are 
emerging public health concerns, especially for gonorrhoea 98,99 . Most STIs are asymptomatic 
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and may not be diagnosed in the clinic settings. Thus, the case-based surveillance system may 
underestimate the prevalence of STIs in the population.  
 
2.5.1 Neisseria gonorrhoea Infections 
 
Gonorrhoea is a one of the very common bacterial sexually transmitted infections among MSM 
in Australia and other developed countries. It is caused by infection with the 
bacterium Neisseria gonorrhoeae (NG). This bacterium tends to infect warm, moist areas of the 
body, including urethra, throat, anus, vagina, eyes and female reproductive tract (the fallopian 
tubes, cervix, and uterus) 100. Gonorrhoea passes from person to person through unprotected 
oral, anal, or vaginal sex. People with numerous sexual partners or those who do not use a 
condom are at greatest risk of infection. Risk behaviours making a person more likely to engage 
in unprotected sex also increase the likelihood of infection, including alcohol use, illegal drug 
use, particularly intravenous drug use and drug use for or during sex (Chemsex) 101,102. 
  
Gonococcal infection can occur at genital as well as extragenital sites (Pharynx and rectum). The 
primary sites for gonorrhoea among MSM include the pharynx, urethra and ano-rectum 103-105. 
Rectal GC is an independent risk factor for HIV acquisition among MSM after adjustment for 
sexual behaviors and other concurrent infections 24,91. Gonorrhoea can occur at all three sites or 
at a single site, with the pharynx being the most common. The prevalence of pharyngeal 
gonorrhoea in MSM ranges from 3% to 15% worldwide.  Symptoms of gonorrhoea usually occur 
within two to 14 days after exposure. However, some people may never develop any symptom. 
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Extragenital infections are often asymptomatic among MSM. Infections can result in dysuria, 
discharge, epididymitis, anal itching, soreness, bleeding and painful bower movements. 
Gonorrhoea is normally asymptomatic in approximately 10% of males. The rate of gonorrhoea 
is much higher in men who have sex with men than in heterosexuals 106. Rises in gonorrhoea 
among MSM raised the concerns because rising rates will increase the probability of 
antimicrobial drug resistance and possible associated rises in HIV acquisition 107-110.  
 
2.5.2 Chlamydia trachomatis 
 
Chlamydia trachomatis (CT) is a common bacterial sexually transmitted infection for both men 
and women. It is one of the most common sexually transmissible infections (STIs) among MSM 
worldwide. It can be transmitted by vaginal, anal or oral sex. Most men and women with CT 
infection have no symptoms 100. If it is untreated, serious sequelae may arise, including ectopic 
pregnancy and infertility in women and epididymitis and proctitis in men. High-risk groups 
for Chlamydia infection are characterized by a large number of partners and an infrequent use 
of preventive measures, such as condom use. Among MSM, the transmission of infection is 
often via anal intercourse.  
 
GC and CT are the most commonly reported notifiable infections among MSM. The Centers for 
Disease Control and Prevention recommends that men who have sex with men (MSM) be 
screened for urogenital GC/CT, rectal GC/CT, and pharyngeal GC. GC and CT, and the behaviors 
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associated with acquiring them, may increase the likelihood of acquiring and transmitting 
human immunodeficiency virus (HIV) infection.  
 
Notifications of Chlamydia infection in MSM have been rising in Australia and globally 10,50. 
Studies conducted in the last decade have convincingly demonstrated that the usual standard 
testing of urogenital sites for gonorrhoea and chlamydia misses most infections in MSM, which 
occur at extragenital sites in the pharynx and rectum, and are mostly asymptomatic 111-113. 
While pharyngeal infections are self-limiting and usually clear within two to three weeks even 
without treatment 114, rectal infections can persist over longer periods, often without severe 
symptoms 115. The majority of pharyngeal and rectal GC and CT infections are asymptomatic 24; 
these infections are unlikely to be detected without routine screening. It is estimated that 
chlamydia infected over 100 million people each year worldwide by sexual transmission. The 
majority of persons with anogenital CT infection are not aware of their infection because it is 
frequently asymptomatic. Urogenital chlamydial infection can lead to serious adverse outcomes 
in women, e.g. pelvic inflammatory disease (PID) that can result in tubal factor infertility, 
ectopic pregnancy and chronic pelvic pain. Urogenital chlamydial infections do not result in any 




2.5.3 Infectious Syphilis 
 
Syphilis is a chronic bacterial infection caused by Treponema pallidum. Transmission of the 
bacterium occurs during vaginal, anal, or oral sex. There are four stages of syphilis: primary (10-
90 days), secondary, latent (within or after 1 year of infection), and tertiary (3 or more years 
after infection). Primary and secondary syphilis are the most infectious stages 100. Syphilis is of 
both individual and public health importance. In addition to its direct morbidity, increases risk 
of HIV infection and can cause lifelong morbidity in children born to infected mothers 117.  
 
Incidence of many acute STIs including Syphilis infection fell substantially among MSM after the 
mid-1980s due to sexual behavioural modification in response to the emerging HIV epidemic. 
However, despite the promising decline of syphilis infections in the late 1990s in many 
developed countries, the Syphilis re-emerged in 2000 and continued to rise recently 118. The 
reemergence in cases of infectious syphilis coincided with an increase with other STIs following 
the introduction of antiretroviral therapy in 1996 which has improved survival and sexual 
wellbeing of people with HIV 119. From 2000 to 2013, the proportion of syphilis diagnoses 
reported among MSM versus non-MSM in high-income countries increased from 26.8% to 55%, 
with all 18 countries reporting an increase of syphilis prevalence among MSM 120. An increase 
has been reported in the numbers and rates (per 100,000) of syphilis infections among MSM in 
the USA and Western Europe since 1998, particularly those with coexistent HIV infection 117,121 
.The reemergence of syphilis occurred almost exclusively among MSM and were attributed to 
increases in risky sexual behaviors such as unprotected anal sex with casual partners, HIV 
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‘serosorting’ and oral sex ,exchange sex, illicit drug use before sex, multiple sexual partners, and 
high-risk anonymous sexual contacts 122. 
 
MSM and men with HIV infection account for a disproportionate burden of syphilis infections 
123,124. WHO estimates 12 million new syphilis cases worldwide each year and MSM are 
estimated to constitute over 60% of the cases 48. Moreover, syphilis has been reported to be 
strongly associated with prevalence of HIV infection among MSM thereby playing an important 
role in the increase of HIV infection in the MSM subpopulation. Syphilis cases are occurring in 
both HIV-negative and HIV-positive MSM, with repeat infections often overrepresented in the 
latter group. In some industrialized countries, the HIV infection increase has been coincided 
with the outbreak of syphilis among the MSM population. Oral sex between men seems to be 
important in the transmission of syphilis outbreaks as unprotected oral sex is considered a safe 
practice among MSM 125. Syphilis transmission attributed to oral sex has been reported 
between 20% and 46% 126.  Syphilis causes inflammatory genital ulcers and lesions in the skin 
which raised concern that syphilis appears to promote the acquisition and transmission of HIV 
127.  Syphilis also complicates the clinical course of HIV by increasing viral load 128. It has also 
been associated with a higher rate of treatment failure in HIV-infected persons 129. The 
interaction between HIV infection and syphilis is complex and remains the great interest of 
ongoing research for the epidemiological and clinical implications that apply to both 




Syphilis remains a global problem despite the existence of simple and validated screening tests 
because syphilis infection is frequently asymptomatic. Annual serological screening for syphilis 
is recommended for the MSM subpopulation and frequent syphilis screening for MSM with 
higher risk in many countries 130,131. This includes serological testing for syphilis every time 
when HIV testing is undertaken and each time HIV viral load testing is performed in HIV-positive 
MSM 132,133. Moreover, only one drug, penicillin, is recommended for syphilis treatment and 
response to therapy is assessed based on changes over months in serological test titres. 
Treatment for patients who cannot receive penicillin and management of patients who do not 
serologically respond to treatment are common clinical problems 117. 
 
2.6 Epidemiology of HIV infection among MSM in Australia 
 
The first AIDS diagnosis in Australia was in October 1982, with the first AIDS death in 
Melbourne on the 8th July 1983 134. HIV testing was introduced in Australia in 1985 and the first 
antiretroviral drugs for HIV infection became available in Australia in 1987, which were initially 
used as monotherapy and then as dual therapy from 1992 135. Cases of newly diagnosed HIV 
peaked at 2,773 in 1987 and then declined to the lowest level in 1999 136. The decline in HIV 
incidence has been largely attributed to the rapid adoption of HIV prevention practices, 
including safe sex education, and world leading needle and syringe programs 135,137. AIDS cases 
in Australia have plummeted from its peak in the early 1990s since the advent of anti-retroviral 
medication in the mid-1990s, which stops HIV from progressing to AIDS. Of the 16,765 newly 
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diagnosed cases of HIV infection between 1984 and 1992, the majority were reported in NSW 
(67%). New HIV diagnoses declined rapidly from 14% in 1985-1986 to 1% in 1991-1992 138. 
 
Trends in HIV diagnoses differ across Australia and are primarily driven by men who have sex 
with men (MSM) 139. The rate of HIV transmission through male-to-male sex reached a peak in 
1983-1984 and declined rapidly in subsequent years. After the Millennium, HIV diagnoses have 
remained stable in Australia over the past decade, and the epidemic remains concentrated 
among gay and bisexual men. Male‑to‑male sex continues to be the major HIV risk exposure in 
Australia with low levels of heterosexual transmission and transmission among people who 
inject drugs. The pattern of HIV diagnoses attributed to male-to-male sex was 86% in earlier 
years. However, females are increasingly being affected by the HIV epidemic in recent years 
135,138. In 2016, 1,013 people were newly diagnosed with HIV 140 and male-to-male sexual 
contact accounted for 712 (70%) new HIV diagnoses, while (209) 21% of the cases were 
attributable to heterosexual sex and both male‑to‑male sex and injecting drug use for 51 (5%) 
diagnoses, and injecting drug use only for 14 (1%) diagnoses 50.  
 
By the end of 2016, an estimated 26,444 people were living with HIV in Australia, with an 
estimated 19,855 (75%) infections were attributable to male-to-male sex exposure. The rate of 
HIV diagnosis is 2.2 times higher among the Aboriginal and Torres Strait Islander people than 
Australian born non-indigenous people (6.4 vs 2.9 per 100,000). Between 2012-2016, there has 
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been a 33% increase in HIV diagnosis among Aboriginal and Torres Strait Islander people 
compared to a 22% decline among Australian born non-Indigenous people 140.  
 
HIV incidence over the five years 2012-2016 varied between 0.58% and 0.85 per 100 person-
years (0.85 per 100 person-year in 2016) among gay and bisexual men attending sexual health 
clinics in the ACCESS network. The self-reported HIV prevalence among gay and bisexual men 
participating in the Gay Community Periodic Survey was 7.3% and 1.4% in people who inject 
drugs 141. Another clinic based study showed the incidence of HIV was above 2.0% in subgroups 
of MSM with specific characteristics at the last HIV negative test 108. The number and rate of 
notifications of HIV infection in Australia in the past 10 years has been relatively stable at about 
1000 per annum and 4.2–4.9 per 100,000 population 50. This is relatively low compared with 
other industrialised countries 142.  
 
2.7 Epidemiology of STIs among MSM in Australia 
 
2.7.1 Gonorrhoea  
 
In Australia, gonorrhoea is predominantly diagnosed in MSM, among young heterosexual 
Aboriginal and Torres Strait Islander people living in remote and very remote areas and 
travelers returning from high prevalence areas overseas. A national epidemiological study on 
gonorrhoea demonstrated that a dual epidemic in Australia among Aboriginal people in remote 
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areas, and non-Aboriginal men in metropolitan areas contributed substantially to the overall 
rise in gonorrhoea notifications 18.  
 
According to the Australian Bureau of Statistics (ABS), over half a million people or 3% of the 
adult population identified as gay, lesbian or 'other’ in 2014 143.  A study has shown that rates of 
unprotected anal intercourse with casual male partners have increased among MSM in 
Australia since 2004 144. Studies have shown that greater sexual risk and potential increase in 
STIs will occur due to widespread uptake of biomedical prevention, such as PrEP for HIV 145,146. 
 
In 2016, there were 23,887 gonorrhoea notifications in Australia, an increase of 185% 
compared to the 8,388 notifications in 2006. Around 75% of notifications were in males (17,325 
notifications). Gonorrhoea notification rates in males were higher in all age groups in 2016 than 
in females except in the 15-19 age group. The rate of notified gonorrhoea in males has nearly 
tripled over the past decades from 53.1 per 100,000 in 2005 to 145.5 per 100,000 in 2016 with 
the majority of cases in MSM 50. However, the surveillance data do not provide a valid measure 
of either the prevalence or change in STI in the general population 21. 
 
Incidence is the best indicator of changes in transmission in a population. Gonorrhoea incidence 
from The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of STIs and 
BBVs (ACCESS) project showed that gonorrhoea incidence was 33.7 per 100 person‑years in HIV
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‑positive gay and bisexual men, 46% higher than that in HIV‑negative gay and bisexual men 
(23.1 per 100 person‑years). In the past five years (2012–2016) gonorrhoea incidence has 
increased in both HIV‑positive (29% increase) and HIV‑negative (30% increase) gay and 
bisexual men, but remained steady between 2015 and 2016. However, these incidence 
estimates represent populations attending sexual health clinics and may not be generalised to 
the broader priority populations 50.  
 
In MSM, gonorrhoea is commonly infected at three sites: pharynx, rectum, and urethra. MSM 
population-based studies have shown that gonorrhoea positivity is increasing among MSM in 
Australia in recent years, particularly among those MSM who had more than 10 sexual partners 
in the last 12 months 147,148. A study conducted in Melbourne among a total of 12, 873 MSM 
reported that the proportion of pharyngeal, urethral and rectal gonorrhoea positivity was 1.7%, 
2.3% and 2.9% respectively among MSM population. 0.9% of MSM were infected at multiple 
sites for gonorrhoea and among the positive cases, 19.1% of MSM were infected at 2 or more 
sites of gonorrhoea 149.  It is also noted that a decrease in consistent condom use between 
MSM and their casual partners and an increase in STI testing have been observed during the 
same time 149. Another MSM population based analysis showed similar increase in gonorrhoea 
positivity has been reported in Sydney 148,150.  A recent study has reported that among MSM 
with urethral gonorrhoea, the proportions with concurrent pharyngeal or rectal gonorrhoea 






Chlamydia is the most frequently diagnosed and notified STI followed by gonorrhoea, HIV and 
syphilis in Australia. According to the national surveillance for STIs in 2017, there were 96, 721 
notifications. However, the unavailable sex preference information making  the estimation of 
chlamydia prevalence in MSM impossible because national surveillance is based on reports by 
clinicians or laboratories of newly diagnosed cases of STI and BBV infection to local State and 
Territory Health Departments 152. The annual surveillance report form The Kirby Institute 
showed that the notification rate of chlamydia was increased steadily between 2007 and 2011, 
remained relatively stable between 2011 and 2015, and increased by 8% from 378.3 per 
100 000 in 2015 to 409.0 per 100 000 in 2016 50. It is important to examine trends in chlamydia 
notifications in the context of patterns of testing, as changes in notification rates can be an 
indication of changes in testing, changes in disease incidence, or both 50. 
 
In 2016, Chlamydia incidence data from The Australian Collaboration for Coordinated Enhanced 
Sentinel Surveillance of STIs and BBVs (ACCESS) showed that chlamydia incidence in 
HIV-positive gay and bisexual men was 37.9 per 100 person-years, which was 1.9 times as high 
as in HIV-negative gay and bisexual men (19.5 per 100 person-years) in 2016. There was a 20% 
increase in chlamydia incidence in HIV-positive gay and bisexual men (from 31.6 to 37.9 per 100 
person-years) and 13% increase in HIV-negative gay and bisexual men (from 17.3 to 19.5 per 
100 person-years) from 2012 to 2016 50.  
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There are few published data on the rate of chlamydia infection in MSM in Australia. One 
Victorian study on 12,873 MSM showed that the proportion of MSM who were infected with anal 
chlamydia was 5.6%, with an average increase of 6% (95% CI, 3%–10%) each year between 
2007 to 2013; however, no significant change was observed in urethral chlamydia positivity 
(adjusted odds ratio, 1.02; 95% CI, 0.98–1.06). Increases in chlamydia positivity were primarily 
restricted to MSM who reported more than 10 partners in 12 months 149. Another study at 
MSHC found that 3.70% (95% CI: 3.30-4.14) were urethral chlamydia positive and 5.36% (95% 
CI: 4.82-5.96) were anal chlamydia positive in MSM between 2002 to 2009 21. 
 
2.7.3 Infectious syphilis 
 
In Australia, there were 4,400 notifications of early syphilis cases in 2017 and majority of early 
syphilis cases are currently found among men (85%). The notification rate of early syphilis cases 
among men has increased in the past ten years, from 4.9 per 100,000 population in 2004 to 
30.6 per 100,000 population in 2017 with the highest notification rates among men aged 25–29 
years 152. Over 90% of syphilis and gonorrhoea diagnosed in major cities and regional areas are 
diagnosed in MSM 50. Nearly half of the cases were in HIV positive MSM, and among these 
MSM, a significant proportion are re-infections 153. 
 
There are very few studies to investigate the rate of infectious syphilis in MSM in Australia. One 
study showed that the proportion of MSM serologically tested for syphilis annually increased in 
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HIV-negative (48% to 91%; Ptrend < 0.0001) and HIV-positive MSM (42% to 77%; Ptrend < 0.0001) 
among MSM attending a national sentinel network of 46 clinics in Australia between 2007 and 
2014. Among HIV-negative MSM, the proportion of infections that were early latent increased 
from 27% to 44% (Ptrend <0.0001), while the proportion that were secondary decreased from 
24% to 19% (Ptrend =0 .030). Among HIV-positive MSM, early latent infections increased from 
23% to 45% (Ptrend <0.0001), while secondary infections decreased from 45% to 26% (Ptrend = 
0.0003). Among HIV-positive MSM, decreasing secondary syphilis correlated with increasing 
testing coverage (r = −0.87; P =0.005) or frequency (r= −0.93; P = 0.001) 131.  
 
2.8 Epidemiology of HIV infection among MSM in the United States of America (USA) 
 
The epidemiology of HIV infection in the United States has changed significantly over the past 
30 years since the first AIDS cases were reported there in June 1981. This earlier epidemic 
began predominantly in young, white, middle-class MSM living in the largest west and east 
coast cities 3,154-156. Today, HIV/acquired immune deficiency syndrome (HIV/AIDS) has a broad 
geographic distribution involving multiple transmission risk behaviours in USA. It has become a 
disease affecting far greater demographic diversity, all ages, genders, races and economic 
status 154.  
 
 In 2016, the number of new HIV diagnoses in the United States was 39,782 with 32,131 
diagnoses among adult and adolescent males (13 years or older), 7,529 among adult and 
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adolescent females, and 122 among children younger than 13 years. The estimated HIV number 
of new HIV infections (HIV incidence) in the United States was 37,600 in 2014 and the 
estimated annual HIV infections in the United States declined 10% from 2010 to 2014. There 
were more than 1.1 million persons aged 13 and older were living with HIV infection (HIV 
prevalence) at the end of 2015, including an estimated 162,500 (15%) persons whose infections 
had not been diagnosed 157.      
 
HIV transmission patterns have shifted over time in the USA. In 2016, most diagnosed cases of 
HIV occurred through male-to-male sexual contact (67%, 26570) of all HIV diagnoses and 83% 
of diagnoses among males. An additional 3% of diagnoses occurred among gay and bisexual 
men with a history of injection drug use. Diagnoses attributable to injection drug use alone 
have declined significantly over time and accounted for 6% of new diagnoses in 2016. 
Transmission through heterosexual sex now accounts for more cases than at the beginning of 
the epidemic – 24% of new diagnoses in 2016 – but diagnoses attributable to heterosexual sex 
have declined 16% between 2011 and 2015 157,158.  
 




MSM comprise at least 4% of males in the USA 159. A review of available national and sentinel 
surveillance data in USA suggested that MSM bear a disproportionate burden of gonorrhoea 
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and an increasing number of MSM have been diagnosed with gonorrhoea in recent years. 
National surveillance data which captures only a fraction of America’s STI burden showed that 
468,514 cases (18.5% increase) of gonorrhoea reported in 2016 with the prevalence rate of 146 
per 100,000 people 160.  
 
A narrative review showed that between 2009 and 2015, 16.6% of MSM tested positive for 
gonorrhoea at any sites; rectal gonorrhoea positivity rate was 11.7%, oropharyngeal 7.3%, and 
urogenital was 9.9%. Positivity increased 12.6% for oropharyngeal and 72.4% for rectal 
gonorrhoea 161. In 2015, there were 26,878 MSM tested for gonorrhoea across the participating 
STD clinics. The median site-specific gonorrhoea prevalence among those tested was 19.0% 
(range by site: 10.9%–22.7%). The estimated incidence of gonorrhoea among MSM in STD 
Surveillance Network (SSuN) sites increased 151% from 1,368.6 cases per 100,000 MSM in 2010 
to 3,434.7 cases per 100,000 MSM in 2015. The rates among women and men who have sex 
with women (MSW) increased a significantly smaller proportion (39.8% and 31.7%, 
respectively) over the same period 162. In a Seattle clinic, the proportion of MSM with 
pharyngeal gonorrhoea was 6.5%, rectal gonorrhoea 9.7%, and urethral gonorrhoea 5.5% (7). 
Almost all urethral infections were symptomatic (96%), but most pharyngeal and rectal 
infections were asymptomatic. Most pharyngeal or rectal infections (58%) were not associated 






Chlamydia is the most common STI in the USA, accounting for nearly three million new 
infections each year, according to the estimates from the Centers for Disease Control and 
Prevention (CDC) based on the National Health and Nutrition Examination Survey (NHANES) 164. 
National surveillance data which captured only a fraction of America’s STI burden showed that 
1.59 million cases (4.7% increase) of chlamydia reported in 2016 with the prevalence rate of 
497 per 100,000 people 160.  
 
During July 2011–June 2012, there were 21,994 MSM tested for chlamydia, 81.4% for 
urogenital chlamydia, 31.7% were tested for pharyngeal CT, and 45.9% for rectal CT. Of these 
MSM tested, 8.4% for urogenital CT, 2.9% for pharyngeal CT, and 14.1% for rectal CT. More 
than 85% of extragenital CT infections were associated with negative urethral tests at the same 
visit and would not have been detected with urethral screening alone. In 2015, the STD 
Surveillance Network collects patient data from 42 STD clinics has showed that 26,694 MSM 
were tested for chlamydia. The median site-specific chlamydia prevalence among those tested 
was 16.0% (range by site: 11.8%–17.6%). 
 
2.9.3 Infectious syphilis 
 
In the USA, the prevalence rates of primary and secondary syphilis are highest among MSM, 
particularly among young and Black MSM 165. Primary and secondary (P&S) syphilis among men 
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who have sex with men (MSM) has been increasing since at least 2000. The number of reported 
primary and secondary syphilis cases among MSM continued to rise in 2016 and the majority of 
primary and secondary syphilis cases remained among MSM. National surveillance data which 
captures only a fraction of America’s STI burden showed that 27814 cases (17.6% increase) of 
primary and secondary syphilis reported in 2016 with the prevalence rate of 9 per 100,000 
people 160. Gay, bisexual and other men who have sex with men (MSM) accounted for 81 
percent (16,155) of male cases where the sex of the sex partner is known in 2016 160. In the 
United States, approximately half of MSM with primary and secondary syphilis were also living 
with HIV. In addition, MSM who are HIV-negative and diagnosed with primary and secondary 
syphilis are more likely to be infected with HIV in the future.   
 
Overall, the data from the studies conducted in the USA documented an increase in syphilis 
cases from their lowest prevalence in 1998. Syphilis cases among MSM were at their lowest 
between 1998 and 2000, and then increased from 2000 and beyond. Several studies have 
reported a consistent increase in the number of syphilis cases among MSM 166-171.  Syphilis case 
data from 27 States reported an increase among MSM from 3.4/100,000 males in 2005 to 
4.0/100,000 males in 2008 170. Using national syphilis case data that was reported to the CDC 
from all States and the District of Columbia, Peterman examined syphilis trends and reported a 
consistent increase in syphilis cases among MSM from approximately 6,000 cases in 2006 to 
14,000 cases in 2013 171. Studies have showed that syphilis increases among HIV-positive MSM 
172,173. Data from these studies suggested that the increases in syphilis trends may be more 
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pronounced among HIV-positive MSM and that increased syphilis transmission may be 
accompanied by increased HIV transmission among MSM and vice versa 172,173. Meanwhile, 
research findings suggested evidence for widening racial and age disparities in syphilis trends 
among MSM in the USA with racial minority (Black, Hispanic, and API) MSM and young MSM, 
especially MSM between 20 and 29 years, may account for the greatest increases in syphilis 
trends among all MSM bearing a disproportionate burden in the USA 169,170,174,175. 
 
2.10 Epidemiology of HIV infection among MSM in Europe 
 
HIV infection has had a large impact in European countries over the last 35 years of the 
transmission among gay and bisexual men at different time periods and in different 
geographical regions. In Northern and Western European countries (Scandinavian countries, 
UK, France, the Netherlands, Belgium, Western Germany, Switzerland, Austria), HIV infection 
started to spread in metropolitan gay communities in the late 1970s and early 1980s, followed 
importations from North America 176. Peak incidences were reached around 1985/1986, when 
the first diagnostic tests became widely available 177. Spontaneous and promoted behaviour 
changes, such as reductions in numbers of anal intercourse partners and increasing condom 
use, contributed to declining incidence of new HIV and STI infections in the late 1980s and early 





In Southern Europe (Spain, Portugal, Italy), HIV initially spread mainly among Injection Drug 
Users (IDUs). However, transmission among gay and bisexual men increased gradually from the 
late 1990s onwards. In Eastern Europe, explosive HIV epidemics developed among IDUs in the 
mid-1990s, followed by increasing incidence of sexual transmission 178,179. In Central and 
Eastern Europe HIV started to spread among MSM from the early 1990s, with incidence initially 
increasing slowly but then accelerating from the early 2000s.  
 
HIV epidemics are attributed to two main modes of transmission: Injecting drug use and male-
to-male sex in the EU/EEA (the European Economic Area). The highest proportion of HIV 
diagnoses (40%) was reported to be in MSM in 2016, which is lower than that in Australia and 
USA. In general, HIV prevalence tends to be higher in Western compared to Eastern European 
countries. In the western and central European countries, MSM account for about half of all 
HIV-infections with known transmission routes. In the eastern European countries, only 1% of 
all HIV infections are reported as being in MSM 53. This may better reflect gender norms and 
unavailable or unreliable information on mode of transmission, due to high stigmatization of 
homosexual behaviour 53,180. In most eastern European countries and some central European 
countries, MSM remain one of the most hidden parts of society. In Eastern Europe heterosexual 
contact and IDU remain the main modes of HIV transmission. MSM remain one of the most 
hidden parts of society and the epidemic among MSM remains hidden and often invisible in 
Eastern Europe. Little is known about their risk behaviour, including injecting drugs, 
international sex tourism and involvement in commercial sex 181.  
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In Europe, EuroHIV (European Centre for the Epidemiological Monitoring of AIDS) coordinated 
the surveillance of AIDS and later also HIV infection between 1984 and 2007. Since 2008, the 
European Centre for Disease Prevention and Control (ECDC) and the World Health Organization 
(WHO) Regional Office for Europe have jointly coordinated HIV/AIDS surveillance in Europe and 
published an annual analysis of the data 181. In 2016, a total of 29,444 new HIV diagnoses were 
reported by the 31 countries of the EU/EEA, with a rate of 5.9 per 100,000 population. The rate 
was higher among men than women (8.9 versus 2.6 cases per 100,000 population). Despite 
three decades of preventive efforts since the early years of the epidemic and decreases in the 
rate of the HIV infection in the last decade, MSM still remain the sub-population most affected 
by the HIV epidemic, with 40% of new HIV diagnoses in 2016 being among this group 53. Studies 
have reported HIV prevalence estimates among MSM ranging from lows of 0% to 3% in some 
Eastern European countries (e.g. Bosnia & Herzegovina, Belarus) to between 10% and 20% in 
some Western European countries (e.g. France, Germany, the UK, Spain, the Netherlands). Data 
from 23 European countries showed an 86% increase in newly diagnosed case of HIV infection 
among MSM between 2000-2006 182. However, data suggest that in Western Europe, trends in 
new HIV diagnosis among MSM were stable between 2006 and 2016. In contrast, HIV diagnosis 




2.11 Epidemiology of STIs among MSM in Europe 
 
2.11.1 Gonorrhoea  
 
The European Surveillance of Sexually Transmitted Infections (ESSTI) network was first 
established in 2001 and is a collaboration of STI epidemiologists and microbiologists from 24 
European countries. The key objective of ESSTI is to collate and analyse surveillance data on 
acute STI in order to inform public health policy and control of STI. Previously, surveillance data 
on STI had been collected at the European level for some time by both WHO and ECDC, until 
recently data on diagnoses in MSM had not been routinely collected.  
  
Since 2008, the overall rate of reported gonorrhoea has been more than doubled across 
Europe. In 2014, 66,413 cases of gonorrhoea were reported by 27 EU/EEA member states with 
the overall notification rate 20 cases per 100,000 population, which was a 25% increase 
compared to that in 2013 and MSM accounted for over 40% of reported gonorrhoea cases. The 
highest rates were reported in the United Kingdom (60 per 100,000), Ireland (28 per 100,000) 
and Denmark (20 per 100,000). Majority of gonorrhoea cases were diagnosed among young 
MSM aged 15-34 years old 183. Population based study in UK showed that 65% of all cases of 
gonorrhoea diagnosed in London in sexual health clinics in 2013 were MSM and these 






Incidence of chlamydia among MSM was in very low levels in EU in the mid-1990s. However, it 
has increased among MSM in Western Europe since late 1990s and early 2000 185. This may 
have been partly due to improved sensitivity of diagnostic tests and the expanded use of 
combination diagnostic tests, in addition to behavioural changes such as increases in partner 
numbers and declines in condom use 181,186. 
 
Information on transmission risk group for chlamydia notifications in the EU/EEA is poor due to 
the availability of data which was just 40% of reported cases in 2014 183. In 2014, the majority of 
cases (87%) occurred in heterosexuals, with only 7% of notifications being among MSM 181. In 
2014, 83% of all chlamydia cases (all transmission risk categories) were reported in four 
countries (Denmark, Norway, Sweden and the UK) and the UK continues to contribute a large 
proportion of reported cases (60% in 2014). Notification rates among MSM were much lower 
than for all transmission risk groups combined. Countries with low but increasing notification 
rates among MSM between 2010 and 2014 included Latvia and Slovenia 116.  
 
The UK had the highest notification rate among MSM, increasing from 14.2 per 100,000 men in 
2009 to 36.2 per 100,000 men in 2014 116.  Surveillance data from sexual health clinics in 
England indicated recent increases diagnoses of chlamydia among MSM increased over 6 times 
(from 2,183 in 2005 to 12,900 in 2016).  Between 2015 and 2016, chlamydia diagnoses 
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remained relatively stable among MSM (1% increase from 12,828 in 2015 to 12,900 in 2016), 
consistent with the increasing trend since 2005 187.  
 
MSM population-based studies have shown similar pharyngeal prevalence of chlamydia with 
1.5%, 1.5% and 1.2% in Germany, the Netherlands and the UK, respectively 188-190.  Rectal 
prevalence of chlamydia was higher at 8.0%, 8.2% and 6.5%, respectively. The Netherland and 
UK studies additionally reported urethral prevalence of chlamydia to be 4.0% and 4.3 
respectively 189,190. 
 
2.11.3 Infectious Syphilis 
 
Similar to syphilis trends among MSM in the US, the epidemiological trend suggested an 
increase in syphilis prevalence over time among MSM in Europe, especially Western Europe. 
Data on the prevalence of syphilis in MSM were very limited in Eastern Europe. However, 
Syphilis incidence has been declining following the major epidemic in the 1990s in Eastern 
Europe. A recent Russian study showed that syphilis incidence declined nationally from 79.4 per 
100,000 in 2004 to 28.9 per 100,000 in 2013, but remains high in some regions, particularly the 
Far Eastern, Siberian and Northwestern Federal districts 191. The declines in Russia are occurring 
against a backdrop of increasing syphilis incidence in the EU/EEA, mainly driven by MSM, 
although even the highest incidence countries have considerably lower rates than Russia (e.g. 
7.2 and 7.7 per 100,000 in the UK and Spain, respectively) 183. In Western Europe, MSM also 
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account for the majority of primary and secondary syphilis cases and remain the group most at 
risk for contracting syphilis. In England, all cases of syphilis (84%) diagnosed in London residents 
in sexual health clinics in 2013 were from MSM. Studies from Western Europe showed that 
syphilis cases among MSM were lowest between 1998 and 2000 and have increased since then 
121. National surveillance data showed a consistent increase in syphilis cases among MSM, 
increasing by 14% from 4,185 in 2015 to 4,788 in 2016 in England 187, increasing from 
approximately 400 cases in 2001 to 1500 cases in 2007 in Germany and from 47 cases in 2008 
to 114 cases in 2010 in Greece 192. Studies in England, Wales, France, Sweden, Scotland and 
Netherland showed an overall increase among MSM despite intermittent periods of decline 
121,193,194.   
 
Very few studies conducted in Europe presented differences in syphilis trends by race and age. 
One study noted that demographic profile of the increasing trends in syphilis in England and 
Wales was comprised predominantly of White MSM 194. Another national surveillance data 
from the Netherlands, did not demonstrate any age differences in syphilis trends among MSM, 
rather showing a decline in syphilis cases among both younger MSM (15–24 years) and older 
MSM (25 years and above) 195.  
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2.12 Factors associated with HIV and STIs among MSM 
 
Causes of HIV and STIs among MSM are complex and multifactorial. Increases in incidence and 
prevalence of HIV and STIs reflect changes in biological, demographic, behavioral and social 
factors, which are important in understanding high HIV/STI transmission rates among MSM.  
Individual level risk factors for HIV and STIs have been well documented globally in MSM such 
as high numbers of sexual partners and anal intercourse, particularly unprotected anal 
intercourse 6,196. HIV prevalence among MSM is so high in many countries means that members 
of this group have an increased chance of being exposed to the virus, due to mainly having sex 
within this group. In summary, factors that put men who have sex with men at heightened risk 
of HIV and STIs include: 
1. Biological factors. High vulnerability to HIV infection among MSM is that unprotected 
anal sex carries a higher risk of transmission than vaginal sex because the walls of the 
anus are thin and more easily torn, creating an entry point for HIV into the bloodstream 
197. Having a STI may also facilitate HIV infection among MSM 83. 
2. Behaviour factors.  Having multiple sexual partners and unprotected anal intercourse 
are more common among this community, and many men who have sex with men do 
not use condoms consistently 198. Access to HIV testing services is low among this group. 
Alcohol and drugs are a common part of socialising in some communities of MSM.  
3. Substances & Chemsex. One of the major factors facilitating the increased risk-taking 
behavior by MSM is the use of disinhibiting substances, including alcohol, crystal 
methamphetamine, and other recreational drugs 7.  
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4. Legal factors. As of May 2016, 73 countries still criminalise same-sex conduct, affecting 
the rights of MSM. In 13 countries including Iran, Sudan, Saudi Arabia, Yemen and parts 
of Nigeria and Somalia, homosexuality is punishable by the death penalty 199. As a result, 
men who have sex with men are less likely to access HIV healthcare services for fear of 
their sexual orientation and identity being revealed. 
5. Social and Cultural factors. Many MSM have experienced homophobic stigma, 
discrimination and violence. This drives MSM to hide their identity and sexual 
orientation 200,201. Many fear a negative reaction from healthcare workers. As a result, 
men who have sex with men are less likely to access HIV healthcare services 202. 
6. Sexual network factors. Focusing on risk behavior alone does not explain why some 
persons and communities continue to be infected with HIV and other STIs more than 
others. Increases in HIV and STIs among MSM have been pronounced in urban areas 
where dense sexual networks, population churn and high prevalence of anonymous 
partnerships sustain ongoing transmission 203. STIs affect individuals, who are part of 
partnerships and larger sexual networks, and in turn populations (Figure 2.1) 5. 
7. Geosocial networking systems and online social networks. Geosocial networking and 
online dating are widely used by MSM worldwide to meet partners for sex and dating. 
Studies indicated that MSM are less likely to use condoms with partners met via 







Figure 2.1 Sexually transmitted infection transmission dynamics at the population level 8 
Arrows show direction of sexual contact between core groups, bridging populations, and general 
population 
 
2.13 Prevention and interventions for STI and HIV among MSM 
 
In order to effectively prevent and reduce HIV and STI transmission among MSM and to 
promote sexual health among MSM, key components of public health programmes have been 
suggested to address HIV and STIs among MSM based on scientific evidence available by WHO 
Collaborating Centre for Gonorrhoea and Other Sexually Transmitted Infections and the 
European Centre for Disease Prevention and Control (ECDC) 4,64. Prevention and interventions 
for STIs and HIV in MSM (Figure 2.1) include: 
1. Vaccination: Promote and deliver vaccination to protect against Hepatitis A and B 




2. Condom: Promote condom use and provide easy access to condoms and lubricants. 
3. Testing and screening for HIV and STIs: Provide voluntary and confidential HIV and STI 
counselling and testing, identify barriers and facilitators to testing for the target group 
and offer partner notification services to support the early diagnosis and treatment of 
contacts. 
4. Treatment provision: Timely provision of treatment for HIV, viral hepatitis and STI for 
patients and their contacts. 
5. Health promotion: Provide accurate and accessible information that enables men to 
understand and assess sexual health-related risks and prevention efficacy, and that 
promotes awareness of one’s own HIV and STI status. 
6. Deliver MSM competent health services: MSM-competent points of care offering a 
comprehensive sexual health programme including health promotion, counselling, peer 
support, prevention, adequate diagnostics and treatment will increase service uptake. 
7. Biomedical treatment strategies that use antiretroviral therapies (ARTs) to prevent HIV 
infection including post-exposure prophylaxis (PEP), PrEP, and treatment as prevention 
(TasP) 4. 
8. Targeted care for HIV-positive MSM: Provide antiretroviral treatment for HIV and 
vaccination; regular STI screening using adequate diagnostics; several efficacious 
medications exist to treat STIs 209; individual counselling, sexual health promotion and 




However, no single measure will effectively control all STIs at a population level. Effective STI 
control will require the political will to prioritise and invest in new interventions together with 
the optimisation of primary and secondary prevention strategies, including integrated sex 
education programmes in schools, strong partner notification programmes that use the latest 
information technology systems and legislative changes for partner delivered antibiotic 
treatment where appropriate, legalised frameworks for sex work, active targeted health 
promotion, accurate surveillance programmes, and accessible health care for all 4. 
 
 





Despite global efforts to control HIV and STIs among MSM, new infections among MSM have 
been increasing since 2000, reaching or exceeding pre-HIV levels. This epidemiological review of 
HIV and STIs among MSM worldwide over the past decades showed a substantial change and 
an increasing trend in the prevalence of HIV and STIs, resurgence of some STIs and 
reemergence of antimicrobial resistance among MSM over the last two decades among MSM. 
The results showed very high prevalence rate of gonorrhoea, syphilis and HIV infection in MSM 
and indicated diversity and heterogeneity of STI prevalence among MSM according to 
geography, race and ethnicity, and HIV status. However, the rates of HIV and other STIs among 
MSM can vary markedly in relation to the time, setting and population whom the studies were 
conducted. These findings provide evidence on the epidemiology of STIs and HIV worldwide in 
MSM and highlight the special need for targeted prevention programmes, screening and 
treatment strategies in this subpopulation. 
 
MSM have continued to be disproportionately affected by HIV and STIs. HIV and STIs diagnoses 
among MSM have increased since the late 1990s, reflecting social, economic and test 
technological changes. Gonorrhoea and syphilis have re-emerged as a major public health 
concerns. Additionally, the alarming increase in gonorrhoea among MSM is of particular 
concern given the propensity of Neisseria gonorrhoeae to develop resistance to successive 
antimicrobials used for treatment 19. Although most STIs are not usually fatal, they result in a 
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substantial burden of disease 3. STIs can also increase the infectiousness of and susceptibility to 
HIV especially among MSM 210. 
 
Detection of gonorrhoea and chlamydia has increased in the rectum and pharynx among MSM 
in recent years with the widely use of nucleic acid amplification tests (NAATs) and the 
awareness of sexual health providers of the value of screening of non-genital sites in the 
absence of symptoms 103. Extragenital screening for sexually active MSM is critical to the 
provision of comprehensive sexual health services for this population. However, the 
significance of positive NAAT at extragenital sites should be interpreted after a detailed clinical 
interview including presence or absence of symptoms, potential risk for reinfection, and 
adherence to treatment 211. Will the increases in infections reflect true increase in incidence, or 
just an artifact of enhanced screening or a combination of both? More research is needed. 
 
HIV and STIs continue to be important public health concerns among MSM and emergence of 
antimicrobial resistance is substantially compromising the effectiveness of treatment globally 4. 
Prevention should remain a public health priority for those at greatest risk. Treatment of 
curable STIs has long been considered an integral component of combination HIV prevention 
packages 212. Improvements in treatment with a better medication or approach, together with 
clinical and public health actions are needed to control STIs and HIV among MSM. STI control 
interventions that complement the highly effective biomedical interventions for HIV prevention 
are needed as part of combination prevention packages. Biomedical HIV interventions play a 
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positive part in STI control through frequent contacts with sexual health services that allow 
regular continued opportunities for primary prevention and comprehensive case management 
of STIs 4. Further research is required to develop effective, evidence-based interventions among 
MSM.  Continued research is needed to understand the effects of TasP and PrEP on sexual 
behaviours and networks that might increase STI transmission. Enhanced biological and 
behavioural surveillance activities are needed to monitor epidemiological changes in STIs in 
MSM who are infected or not infected with HIV, antimicrobial resistance, and the emergence or 
re-emergence of new sexually transmissible pathogens 4. 
 
There are some key differences in addressing prevention strategies between HIV and STIs. 
Condoms have been the cornerstone of HIV and STI prevention, which can reduce the risk of 
other STIs, such as gonorrhea, chlamydia, herpes and syphilis 213. Safer sex messaging and 
prevention counselling need to emphasize that the correct and consistent use of condoms is a 
very highly effective method of preventing the sexual transmission of HIV 214. However, the 
simple message of “always use a condom” no longer reflects the diversity of non-condom-
based HIV prevention options available to MSM in the era of non-condom HIV risk-reduction 
options continues to increase, such as PrEP and serosorting and strategic positioning 215,216. 
Meanwhile, condoms are less effective at preventing the transmission of STIs that are spread 
through skin-to-skin contact, including warts, herpes and syphilis 217. Two highly effective 
strategies, PrEP and use of antiretroviral treatment as prevention can reduce the risk of HIV 
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transmission but unfortunately cannot protect against STIs 218. Importantly, STIs may increase 
the risk of HIV transmission while using some of these prevention strategies 119,219,220.  
 
2.15 Future directions to reduce STIs and HIV among MSM 
 
Because of the enormous burden of STIs and their wide-ranging adverse health effects, decisive 
action will be an essential part of efforts to meet the health component of the Sustainable 
Development Goals, and the targets of the global health sector strategy on sexually transmitted 
infections 2016–2021 221, which were adopted by the 69th World Health Assembly in May 2016. 
Based on the literature review on the epidemiology of HIV and STIs in MSM, there are many 
implications for HIV and STIs prevention, diagnoses, treatment and care.  
 
As the use of non-condom HIV risk reduction options continue to increase, MSM living with 
positive HIV need to be actively monitored in addressing the rising rates of STI among MSM 
population. In order to improve screening, testing and treatment for STI and HIV preventions, 
sexual health providers should integrate HIV and STIs preventions together with a range of 
preventive measures targeting MSM populations including the combinations of biomedical, 
behavioral, and structural interventions 222,223. These would ideally involve an array of 
prevention contexts, including (1) effective health information communications and practices 
among sexual partners, (2) transactions between individual clients and their healthcare 
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providers, and (3) comprehensive population-level strategies for prioritizing prevention 
research, ensuring accurate outcome assessment, and formulating health policy 222. 
 
As network factors have a significant impact on STI incidence among MSM, more interventions 
to reduce STIs should be focused on social and sexual networks, rather than individual factors. 
Prevention strategies should utilize the online or dating apps as a forum to educate MSM about 
HIV and STI risk behaviours and sexual health responsibilities (e.g., condom use, PrEP uptake 
and adherence, serostatus assumptions), and to disseminate information on how to best 
prevent the contraction and spread of HIV and other STIs. Future studies should focus on 
potential relationships between long-term or consistent use of online dating or apps and HIV 
and STIs incidence in MSM. 
 
Antimicrobial resistance in Neisseria gonorrhoeae especially among MSM puts an emerging 
threat to effective treatment of gonococcal infections, which calls for global surveillance and 
international collaboration action 112,195,224,225. Research and efforts are needed in the following 
areas: development of gonococcal vaccine in conjunction with early detection and screening 
strategies including asymptomatic infections, enhanced partner notification and treatment, 
develop new diagnostic and novel treatment options in order to achieve a 90% reduction of 




Epidemiological information collected from STI surveillance system enable health authorities to 
conduct efficient planning, monitoring and evaluation of intervention activities for STIs and HIV. 
The evidence-based information on transmission patterns of HIV and STIs and potential impact 
on planned intervention activities are required to make appropriate political and programmatic 
decisions at both local and international level. Therefore, a quality HIV and STI surveillance 
system is an essential element of HIV/AIDS and STIs control and prevention program. STI 
surveillance should include (1) routine systematic recording and reporting of numbers of STI 
patients seen at all health care facilities or sentinel surveillance, (2) special studies to collect 
information on proportions of individuals infected with STIs in different population settings, (3) 
special studies to determine the most common microbial causes of specific STI syndromes, and 
(4) special studies to determine the effectiveness of selected drugs for a specific STI pathogen, 
or monitoring the prevalence of antimicrobial resistance among specific pathogens 51. 
 
2.16 Gaps in the current literature and the basis for the research project 
 
As evidence from this literature review, there is an expansive body of international literature 
describing the epidemiology of HIV and STIs in MSM. Studies have shown that very high 
prevalence rate of gonorrhoea, syphilis and HIV infection in MSM. However, there are a few 
gaps. These gaps suggest a need for focused epidemiologic and health services research to 
better characterise STI epidemiology, seasonal variation patterns of STI, HIV testing and 
treatment efficacy for STI. The following section highlights research gaps in this area.  
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The rates of sexually transmitted infections are rising rapidly in MSM. Gonorrhea is of particular 
concern because rising rates will increase the probability of antimicrobial drug resistance. The 
infection rate of gonorrhea is much higher in MSM than that in heterosexuals 80,227. There are 
limited published studies that have specifically investigated the sexual orientation disparities in 
STIs and the relationship between sex work, policing and transient STI epidemic among 
heterosexuals 228. It is therefore important for studies to be conducted to understand factors 
associated with the STI epidemic among heterosexuals. 
 
Currently, the reasons for the higher rates of urethral gonorrhoea in summer remain unknown 
and there are limited studies that have examined seasonal variation in gonorrhoea and risk 
factors associated with gonorrhoea in MSM in Australia. Consequently, studies are required to 
assess the seasonal variations in gonorrhoea in order to allow policy makers to target demand 
for clinical services and health promotion activities to the periods when higher service demands 
are needed, to inform the design and timing of health promotion activities to reduce STI rates 
in Australia 229. 
 
MSM remain the group most at risk of acquiring HIV worldwide. No single intervention 
measurement is likely to control HIV at a population level; however effective prevention 
strategies should start with HIV testing. A positive test result enables planning to effective 
treatment which could prevent others from becoming infected. In many countries, current HIV 
testing efforts are insufficient to identify new HIV infections early enough, and substantial 
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proportions of people with HIV are unaware of their infection 230. HIV treatment promise to be 
an important public health measure for the prevention of HIV transmission 231. A large 
randomised controlled trial showed early initiation of treatment reduced the risk of sexual 
transmission by 96% 49. There is a gap between evidence and practice in the implementation of 
HIV testing programmes in populations. Studies are required to examine the current HIV testing 
among the MSM population in Australia in order to provide data on HIV testing rate. 
 
As rectal chlamydial infection is associated with increased risk of HIV seroconversion, screening 
patients who reported receptive anal intercourse and effective treatment for rectal chlamydial 
infection are critical for HIV prevention 24,232. Current STI treatment guidelines recommend 
rectal chlamydia to be treated with a single 1 g dose of azithromycin or 7 days (100 mg twice 
daily) of doxycycline 233. Improvements to the treatment can reduce the incidence of STIs. 
However, there are ongoing concerns about treatment failure with rates from 13% to 21% have 
been reported 234,235. The available evidence is poor and there are no pharmacokinetic data 
available for azithromycin in rectal mucosa. Given that HIV and STI rates continue to increase 
among MSM and anal sex is increasing in women, treatment for rectal chlamydia infection must 
be efficacious 45. As a result, research is needed to evaluate the efficacy of single-dose 
azithromycin and 1 week of doxycycline for treating rectal chlamydia. 
 
The knowledge gaps summarised above represent important areas for future research. 
Addressing these gaps will provide a better understanding of epidemiology of STIs among MSM 
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STIs constitute a huge health and economic burden worldwide including Australia 27,236-238. 
Despite decades of global control efforts have been made to reduce their high global incidence 
and prevalence, HIV and STIs still remain a significant public health challenge and many 
countries still observed simultaneous increases of HIV and STIs including Australia, especially 
among MSM. STI control is a public health outcome measured by reduced incidence and 
prevalence 239 and STI epidemiology research provides the scientific rationale for public health 
decisions. One of the public health approaches to the control of STIs is to identify population-
based strategies that can be targeted to these risk groups 240.  
 
In Australia, there were a staggering 23,887 new diagnoses of gonorrhoea in 2016, with about 
three quarters of all diagnoses in males (17,325, 73%), up from 8,388 cases in 2006. The 
number of new diagnoses of gonorrhoea has nearly tripled within a decade. Similar trends were 
observed in syphilis and chlamydia. For instance, Syphilis cases have been more than tripled, 
while cases of chlamydia have increased by 43 percent in the past decade 17. Similar increase in 
STIs has also been observed in Adelaide, South Australia 241.  
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This research was conducted within the context of increased diagnoses of STIs, control of STIs 
and prevention of HIV transmission in a sexual health clinic setting at the Adelaide Sexual 
Health Centre (ASHC). ASHC is a sentinel surveillance site for STIs in South Australia. Sentinel 
surveillance is an active surveillance system that can provide early indication of an outbreak 
and provide accurate detailed data. This thesis examined the trends in rates of diagnoses of STI, 
HIV testing, investigated factors associated with STI epidemic, seasonal patterns of STI and HIV 
testing and evaluated treatment efficacy for STI among MSM and heterosexuals. Longitudinal 
data were used to determine whether there has been a change in STI diagnoses, seasonal 
patterns, HIV testing and factors associated with them at the Adelaide Sexual Health Centre 
(ASHC) in South Australia and compared with those at Sydney Sexual Health Centre (SSHC) 
(New South Wales) and Melbourne Sexual Health Centre (MSHC) (Victoria). Findings from this 
study not only provide an overview of past and current STI epidemic, HIV testing and STI 
treatment efficacy among MSM and heterosexuals in South Australia, but also offer insights for 
future HIV and STI intervention programs planning and implementation, with important health 
policy implications for HIV and STI control and prevention.  
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7.2 Key findings of the study 
 
In light of the increase in STIs and challenges and difficulties in STI control, the combined papers 
in this thesis contribute new and important knowledge regarding STI epidemiology, HIV testing 
and STI treatment efficacy among MSM and heterosexuals in Adelaide from both a clinical and 
a public health perspective.  
 
Chapter 2 reviewed the local and international epidemiology of HIV and STIs among MSM to 
identify effective prevention intervention strategies for MSM; described the factors associated 
with sexual risk in this population and provide recommendations for effective prevention 
intervention; highlighted the knowledge gaps, and therefore the rationale for conducting this 
research.  
 
Chapter 3 studied the gonorrhea notifications at ASHC over the last decades and the results 
showed the proportion of gonorrhoea diagnoses was higher between 2006 and 2010 among 
heterosexual men (5.34% vs 0.84%, p<0.001), non-sex worker women (0.64% vs 0.28%, 
p<0.001) and female sex workers (FSWs) (1.75% vs 0.24%, p<0.001) compared with other years 
at ASHC. Such phenomena were not found at the Melbourne Sexual Health Clinic and the 
Sydney Sexual Health Centre, with the data showing that FSWs were less likely to have 
gonorrhoea between 2006 and 2010 than the other groups ( p=0.746, p=0.522, p=0.024, 
104 
 
respectively). For women at ASHC, the odds of gonorrhoea was significantly associated with sex 
worker in epidemic years between 2006 and 2010 (OR 2.8, 95% CI 1.48 to 5.27, p=0.002). It is 
also noted that charges against sex workers peaked in 2007/2008 coincided with the 
gonorrhoea epidemic in Adelaide. Meanwhile around the same time convictions against FSWs 
peaked in Adelaide with 78 prostitution offences in the 2007/2008 financial year compared 
with 450 over the last 12 years; newspaper reports of increased police actions against FSW 
where carrying condoms had been used by police as evidence of sex work. The findings 
suggested increased policing can reduce access to condoms for FSWs, thereby increasing rates 
of unprotected sex 228. It would appear that governments should consider legislative revisions 
to stop using possession of condoms as evidence of sex work. 
 
Chapter 4 analysed the trends in gonorrhoea diagnoses among MSM at ASHC. We formally 
tested this hypothesis of seasonal patterns in STI against data from a similar period at three 
sexual health services in Australia (Adelaide, Melbourne and Sydney). The results showed more 
peaks of gonorrhoea cases were observed in the first quarter of the year in Adelaide and 
Sydney and in the second and fourth quarter in Melbourne. Factors independently associated 
with urethral gonorrhoea at ASHC were being a young MSM, especially those aged 25–29 (OR: 
2.66, 95% CI: 2.00–3.54), having more than one sexual partner (OR 1.71, 95% CI: 1.43–2.04), 
having had sex interstate and overseas (OR 1.52, 95% CI: 1.06–2.17), and presenting in the first 
quarter (OR 1.30, 95% CI: 1.10–1.55). The findings suggest that gonorrhoea among MSM occurs 
in a seasonal pattern, particularly late summer into early autumn. This has implications for the 
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provision of health services over the year and for the timing of health promotion activities and 
resource allocation. 
 
Chapter 5 examined the trends in HIV testing among MSM at ASHC over the past two decades 
in response to effective HIV prevention and care. The findings showed the proportion of newly 
registered MSM who reported ever being tested for HIV declined (Ptrend = 0.030), the 
proportion who reported recent HIV testing did not change (Ptrend = 0.955) and the proportion 
who have had current HIV testing increased (Ptrend = 0.008). The proportion of MSM who 
returned to the clinic for HIV testing within 12 months did not change (Ptrend >0.05), with less 
than 40% of MSM returning for HIV testing. Factors independently associated with recent HIV 
testing included MSM aged 20 years, (OR 1.79; 95% CI 1.53–2.10), higher education (OR 1.28; 
95% CI 1.12–1.45), non-Caucasian (African OR 1.68; 95% CI 1.30–2.17), having multiple sex 
partners (OR 1.47; 95% CI 1.29–1.69), having had sex interstate (OR 1.61; 95% CI 1.42–1.82) or 
overseas (OR 1.53; 95% CI 1.33–1.76) and injecting drug use (OR 1.56; 95% CI 1.29–1.88). The 
study suggests that HIV testing rate among MSM attending ASHC was suboptimal. New 
approaches are needed to increase the uptake and early detection of HIV infection among the 
high-priority MSM population. 
 
Finally, Chapter 6 evaluated the treatment efficacy of two treatments for rectal chlamydial 
infection. The results showed that rectal chlamydia prevalence was 6.7% and 8.1% respectively 
in men and women who presented to the clinic with a rectal swab over the study period. 
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Treatment with azithromycin was significantly associated with 3-fold higher risk (RR 3.35; 95% 
CI 1.31-8.55) of repeat rectal chlamydial infection 14-180 days after treatment commenced. 
The significant association of treatment regimen with repeat rectal chlamydial infection 
remained after adjusting for other factors. Our findingssuggested that azithromycin was 
associated with repeat rectal chlamydial infection, comparing to doxycycline. These findings 
add to the growing body of evidence suggesting that doxycycline may be more effective than 
azithromycin for the treatment of rectal chlamydia in men and women. A randomised control 
trial is needed to evaluate the treatment regimens for rectal chlamydial infection. 
 
7.3 Strengths, limitations and challenges 
 
This research project has addressed knowledge gaps in relation to STI epidemiology, seasonal 
variation patterns of STI, HIV testing and treatment efficacy for STI in Adelaide. These findings 
make an important contribution to the knowledge of STI epidemiology and HIV testing in the 
South Australia and provide evidence for the SA government to stop using possession of 
condoms as evidence of sex work and to consider legislative revisions. The studies have also 
examined the potential risk factors associated with STI epidemic by comparing the differences 
at three sexual health services, one each in Adelaide, Melbourne and Sydney; Effectiveness of 
STI treatments was also evaluated in order to inform prevention efforts, to provide policy 
implications and suggestions for governments and NGOs for the effectiveness of prevention 
interventions of STIs, especially among MSM population. Interpreting STI trends in clinic level 
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data is difficult because national surveillance does not capture contextual information on the 
determinant of incidence. However, the ASHC has collected demographic, clinical and 
epidemiological information on every clinic attendance since 1990. A particular strength of the 
research project is that quantitative research design was conducted from South Australia, to 
complement data from other states in Australia on STI epidemiology, seasonal variation 
patterns of STI, HIV testing and treatment efficacy for STI.  
 
The main limitations of this research project have generally addressed in each of the chapters, 
thus only a few will be mentioned in this section. All the studies used a retrospective and 
observational study design. Data were taken from the computerised database of the records of 
all the clinical visits to the ASHC since 1990.  Retrospective study is subject to the selection and 
recall biases and therefore dependent on the quality of recorded data. Only association and not 
causation can be inferred from the results because the observed association is not randomised 
there could be confounding factors which may have influenced the results. In particular, it was 
not possible to measure and then control for all factors that may have affected the outcome 
through statistical analysis.  
 
 
7.4 Policy implications and recommendations 
 
Evidence from the data of epidemiological trends from ‘Australian National Notifiable Diseases 
Surveillance System (NNDSS)’ by the Department of Health and Ageing and ‘Annual Surveillance 
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Report on HIV, viral hepatitis and STIs in Australia’ by The Kirby Institute suggest that HIV and 
STIs are still major public health concerns in Australia 17,242; STIs other than HIV have been 
neglected as a public health priority and control efforts continue to 3,5. Multiple studies 
supported STIs can facilitate HIV transmission by increasing both HIV infectiousness and HIV 
susceptibility 210,243. With the introduction of PrEP for HIV prevention in recent years, a rapid 
and re-emergence of reported STI cases and a high prevalence of STIs at populations with high 
risk will further increase the sexual transmission of HIV in Australia 146,244-247. ‘Know your 
epidemic, know your response’ is of paramount importance in developing timely and 
appropriate policies, programs and strategies for HIV and STI prevention 248. It is important to 
understand the epidemiological characteristics of an epidemic which is a main principle for STI 
control and prevention. It will not only to generate knowledge, but also to make subsequent 
steps to control and ultimately eradicate the infections. Based on the research findings from 
this thesis, the following implications are made: 
 
7.4.1 Implications and recommendations for policy 
 
 Legislative revisions 
Prostitution in Australia is governed by state and territory laws, which vary considerably among 
different jurisdictions. Prostitution is illegal in South Australia, under the Criminal Law 
Consolidation Act 1935 249 and the Summary Offences Act 1953 250. However, prostitution is 
regulated in Victoria 251 and legal in New South Wales 252. Lessons learned from other countries 
where sex work is legal suggest that sex workers who engaged in commercial sex but do not 
109 
 
participate in the licensing regime are usually less healthy than licensed sex workers 253. The 
legal context appeared to affect the conduct of health promotion programs targeting the sex 
industry. The decriminalization of prostitution is associated with better coverage of health 
promotion programs for sex workers 254.  New York City has stopped using possession of 
condoms as evidence of sex work since 2013. The research findings from Chapter 3 suggested 
that there had been increased local gonorrhoea transmission during the epidemic years which 
could reflect restricted access to clinical services, reduced condom use, or a transient increase 
in heterosexuals. In the interests of public health interventions aimed at the prevention of HIV 
and STI transmission, South Australia parliament and government should consider similar 
legislative revisions, after extensive consultations with different stakeholders including police 
and health authorities 255.  
 Sexual health education and resource allocation for clinical services 
A better understanding of seasonal patterns in STIs is likely to result in better implementation 
of the optimal control strategies 256. A seasonal pattern may appear as a tight cluster of isolated 
epidemics that occurred during a relatively short time period, then spreading over a wide 
geographic area 257. Possible explanations for the seasonal difference in STI diagnoses may 
include: (1) changes in biological rhythms in reproductive hormone concentrations and sexual 
activity; and (2) changes in social opportunity for sex, such as holidays and social events. Our 
study has demonstrated a seasonal pattern in STI diagnoses, with the peak number of 
gonorrhoea cases in summer. The peak of STI diagnoses is representative of corresponding 




The results from Chapter 4, together with other studies, have policy implications to the health 
authority in terms of sexual health education and promotion programs prior to the epidemic 
season and resource allocation including staffing, service access, service provision and quality of 
care. A study by Wellings found the prevalent seasonal variation in risky sexual behaviours, 
suggested the need to schedule pre-emptive school sexual health promotion programs prior to 
the times of high risk, in the spring, summer, and fall 259. Clinical interventions should broadly 
incorporate STI management approaches for symptomatic patients, screening for 
asymptomatic infections and management of STIs in sex partner strategies 239. Public health 
education and promotion should focus on promoting sexual safety and for the timing of health 
promotion activities, especially in warm seasons rather than in winter; perhaps health 
promotion campaigns should intensify during these times of year 229. Delays in seeking 
preventive services may reflect the influence of seasonal barriers. Sexual health clinics may 
consider additional resource and staffs for increasing the availability and access to health care 
and counselling services in the summer and during holidays at Christmas and the New Year and 
social events such as Sydney’s Mardi Gras 229,259,260. 
 Ongoing promotion of comprehensive testing 
There has been great effort made to increase the uptake of testing for HIV and other STIs, 
especially among MSM population at sexual health clinics over the last decade in Australia. 
MSM are one of the populations particularly at increased risk of STIs such as gonorrhoea, 
chlamydia, syphilis and HIV 237. However, HIV and STI among the MSM are still under testing, 
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increasing the likelihood of undiagnosed infections and onward transmission and disease 
sequelae 261,262. Apart from Australian HIV and STI testing guidelines, a variety of other 
approaches has been used to promote comprehensive STI testing in Australia 263. Current 
Australian guidelines recommend that MSM should be tested at least once a year for a range of 
STIs and up to 4 times a year for HIV positive men, men who had more than 10 sexual partners 
in the previous 6 months, participate in group sex or use recreational drugs during sex 264.  The 
Chapter 5 in this thesis showed that HIV testing rate among MSM attending ASHC was 
suboptimal. Another Australian study showed that there was poor adherence to 
national guidelines that recommend regular re-testing of MSM for STIs, particularly among 
those at higher risk who require more frequent testing. Clinical strategies and practices are 
urgently needed to encourage more frequent HIV/STI testing among MSM, especially in the 
higher risk subgroup 261. In addition, there is a need for the government to invest and to 
strengthen health systems that can deliver necessary health services for diagnosis and 
management of STIs, enhance the surveillance and reporting systems and encourage the 
development and implementation of effective strategies to increase the uptake and 
comprehensiveness of testing in future, particularly the promotion of regular comprehensive 
testing for all sexually active MSM, regardless of sexual practice. 
 Clinical practice, service delivery and treatment recommendations 
Management of STIs requires a multidisciplinary approach. WHO’s Department of Child and 
Adolescent Health has expressed that research, policy, and service delivery options for STI 
prevention and treatment is a healthcare priority 265. The Chapter 6 found that that patients 
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treated with azithromycin had a significantly higher risk of repeat NAAT positivity in the rectal 
specimens compared with patients treated with doxycycline, yet testing for reinfection was not 
routine clinical practice and we cannot differentiate between persistent infection and 
reinfection in the absence of genotyping. The results from Chapter 6 have policy implication for 
retesting guidelines relating to ‘test of reinfection’ for clinical practice.  
 
Meanwhile, the research findings from Chapter 6 and other emerging data suggest increased 
failure rates with oral azithromycin compared to doxycycline when used for the treatment of 
rectal CT infections 43,44,235. Suboptimal treatment efficacy for rectal chlamydia with 
azithromycin could have important implications for women who may be infected with CT at 
both urogenital and recital sites. Knowing whether rectal CT infection is present or absent could 
help guide clinicians in formulating their treatment recommendations in favour doxycycline 
over azithromycin 266. 
 
7.4.2 Implications and recommendations for research 
 
 Epidemiological studies  
Epidemiological data on STI epidemic, HIV and STI testing activity and trends, health services 
accessibility (including resource allocation) and timing for health promotion intervention, 
especially for high risk populations are lacking in South Australia. There is a need for the health 
authorities, hospitals, and public health organisations to regularly evaluate STI trends and 
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prevalence; to establish behavioural surveillance among the risk populations; to assess 
behaviour and risks related to STI transmission among different populations; to develop 
guidelines to promote HIV and STI testing in South Australia. The findings from this thesis 
highlighted important features of STI epidemiology, trends in STI diagnoses, seasonal patterns 
in STI, HIV testing and factors associated with testing and treatment efficacy for STI among 
MSM and heterosexuals at ASHC in South Australia, using existing clinical records for analyses. 
This methodology can be used where routine STI surveillance is limited and offers a new 
approach to obtaining critical information on STI prevalence.  
 Behaviour studies 
Sexual behaviour remains the key determinant for STI transmission. Behavioural surveillance 
programmes have enabled the description of population patterns of risk behaviours for STI and 
HIV transmission, which are helpful in the understanding of how epidemics of STI are generated 
267. Behavioural surveillance paired with monitoring of comprehensive of STI trends yielded 
good results and provided information for recommendations 268.  
 
Despite decades of global control effort to reduce their high global incidence and prevalence, 
many countries still observed simultaneous increases of HIV and STIs. In Australia, between 
2012 and 2016, gonorrhoea notification rates have increased by 63% (62 to 101 per 100,000) 17. 
These increase have been attributed to increasing high risk sexual behaviour, including 




Since the late 1990s, combined analysis of both behavioural surveillance data and STI biological 
surveillance data forms a “second generation surveillance”, and has been recommended by the 
Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organisation (WHO) 
working group of Global HIV/AIDS and sexually transmitted infection (STI) Surveillance 269. 
Although Australia has established the behavioural surveillance and has been a joint project of 
the National Centre in HIV Epidemiology and Clinical Research and the National Centre in HIV 
Social Research since 1996, the sample sizes and source population are very limited in the 
scope of analyses in South Australia 270,271. The lack of behavioural data limits the 
understanding of the changes in the HIV and STI epidemic among populations including MSM 
271.  In order to assess the risks related to STI epidemic and provide information for planning 
and public health interventions, current STI surveillance should be supported by regular 
behavioural studies using set of indicators, targeted particularly at MSM, where most STI 
infection occur.  There is a need for consistent and dedicated data collection on systematic 
HIV/STI behavioural surveillance among high-risk populations for better understanding of the 
HIV/STI epidemic and better targeted prevention strategies. 
 
7.5 Future research directions 
 
This research project has answered defined research questions related to trends and factors 
associated with STI diagnoses, seasonal patterns and HIV testing, as well as treatment efficacy 
for STI among MSM and heterosexuals. However, there is a need for regular evaluation of 
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sexual behaviours and trends, HIV/STI testing, HIV treatment as prevention, substance use, etc. 
Future studies should be focused in the following areas: 
 
7.5.1 Further investigation of relationship between sexual behaviors and HIV/STIs  
 
Monitoring trends in sexual behaviours plays an important role in HIV/STI control and 
prevention. Available study has highlight the improvements that need to be made to ensure 
that MSM achieve the best prevention outcomes such as willingness to participate in annual 
HIV and STI testing, and consistent condom use for sexually active MSM 272. There is currently 
limited research on changes in sexual behaviour, especially HIV-seroadaptive behaviours; 
changing patterns of drug use and associated behaviours and evaluation of STI testing and 
treatment as prevention as an effective prevention strategy, specifically with respect to 
prevention outcomes among MSM. More research is therefore needed to evaluate whether 
changes in sexual behaviour, especially HIV-seroadaptive behaviours have probably led to the 
increased incidence and prevalence of STIs in this population 187,272-275.  
 
7.5.2 Enhancing and promoting the update of regular HIV/STI testing among MSM 
 
Barriers to HIV/STI testing may include fear of positive results, difficulties accessing sexual 
health services, provider perceptions of low risk, lack of provider knowledge, and limited clinic 
capacity to meet STI testing needs 276. Study has shown that testing behaviour was associated 
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with sexual risk behaviour, but motives to test consistently remain unclear 277. Evidence-based 
testing guidelines are needed to achieve optimal reductions in STI transmission in the future. 
 
7.5.3 Evaluation of HIV treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP) 
strategy  
 
TasP and PrEP are important strategies to reduce HIV transmission, which may be particular 
relevance of for MSM, who accounts for more than half of the HIV infections 17,278. Current data 
are limited regarding treatment as prevention as an isolated prevention strategy, specifically 
with respect to prevention outcomes among MSM. According to the available literature, 
treatment as prevention appears to significantly reduce HIV transmission. In randomized 
control trials, treatment as prevention has significantly prevented onward HIV transmission 
49,279, but several observational studies have not consistently replicated the findings 55,280. In the 
era of biomedical HIV prevention, STIs are increasing in many populations, bringing new 
challenges and opportunities. PrEP has created a tension between HIV and STI prevention that 
needs to be confronted: condomless sex is becoming more frequent 281. Additional research is 
needed to evaluate the effectiveness of antiretroviral therapy in the real world sexual practices 
and clinical practice to further inform clinical guidelines and recommendations 282-285. Studies 
primarily aimed at biomedical HIV prevention are needed to incorporate designs to include STI 




7.5.4 Demand for more knowledge of increasing resistance and decrease susceptibility to 
antimicrobials 
 
Antimicrobial resistance in Neisseria gonorrhoeae is increasing relentlessly and adverse 
consequences of chlamydia infection remain prevalent 61,286.  Neisseria gonorrhoea 
has developed resistance to all classes of antibiotics of used for empirical 
treatment, and clinical treatment failure caused by extensively resistant strains 286. Limited 
studies that investigated factors contributing to antimicrobial-resistant Neisseria gonorrhoeae, 
especially from low- and middle-income countries where both gonorrhoea and antimicrobial 
resistance are most common 286. Future research studies should focus on associations with 
increased risk of antimicrobial-resistant neisseria gonorrhoeae in older age groups and amongst 
travelers, as well as those with decreased risk of Antimicrobial-resistant Neisseria gonorrhoeae 
in black and Aboriginal groups living in high-income countries. Establishment of surveillance 
systems for antimicrobial resistance, improved currant surveillance system that collects key 
information such as age, same sex partnerships, travel-associated sexual partnerships, and 
sentinel surveillance in specific groups, might allow earlier identification of emerging resistance 
and of risk factors that could alert more intensive follow-up and prevention interventions in 




7.5.5 Exploring substance use during sex (‘chemsex’), alcohol and illicit drug use among MSM 
population 
 
Intensive recreational drug use may be facilitating increase STI transmission 274,287,288. Interest in 
substance use among MSM has emerged from a concern about how ‘chemsex’ might increase 
the likelihood of acquiring or transmitting of HIV/STIs. Despite being the focus of widespread 
research, health provider and media attention, data relating to the prevalence and profile of 
substance use among MSM are incompleted and the role of substances in sexual risk-taking 
behaviours is still poorly understood 289. Changing patterns of drug use and associated 
behaviours should be monitored to enable sexual health services to plan for the increasingly 
complex needs. MSM attending sexual health services should be assessed for recreational drug 
use and disclosure should prompt health promotion, harm minimization and wellbeing 
interventions.  
 
Many challenges still remain to be addressed, including identifying political, socioeconomic and 
cultural factors that limit recognition of HIV/STIs as an important public health problem; and 
finding effective ways to target priority populations with HIV/STI prevention measures. More 
research is needed to develop and implement effective and long-lasting policies and prevention 
measures, which should focus on behavioural risks, enhance HIV/STI testing and treatment 





7.6 Closing remarks 
 
Sexually transmitted infections (STIs) are a growing and major public health concern, which can 
facilitate the transmission of HIV and are associated with severe disease.  In recent years, some 
STIs have begun to (re)emerge at high rates, particularly among MSM in high-income countries. 
Moreover, treatment for some STIs, especially gonorrhoea, has been compromised by 
antimicrobial drug resistance. Much progress has been made in the detection, treatment, and 
prevention of HIV and other STIs in Australia. However, notifications of HIV and other STIs have 
been on the rise for the past decade in Australia. The studies described in this thesis have 
increased our knowledge and understanding of STI epidemiology, seasonal variation patterns of 
STI, HIV testing among MSM and heterosexuals. Furthermore, the study sheds light on the 
treatment efficacy of antibiotics for STI in South Australia. 
 
The research described in this thesis was an exploratory look at STI epidemiology, seasonal 
variation patterns of STI, HIV testing and treatment efficacy for STI in South Australia. Based on 
quantitative analyses, a number of important findings emerged regarding STI epidemiology 
among MSM and heterosexuals. The results of this study will be helpful to increase the 
awareness of the scope of the STI problem and to demonstrate the application of biology, 
epidemiology, and behavioral aspects of STIs to the development of public health policy and 
programmes. Public health policy development and practice for STI control and prevention 
should include behavioral interventions and medical screening/treatment intervention of 
sexually transmitted infections. Epidemiological studies are needed to monitor changing 
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epidemics and trends of HII/STIs over time, evaluate interventions and clinical outcomes, and to 
guide public health policies and strategies to minimise further burden of STIs. To enrich the STI 
control and prevention strategies, a multidisciplinary collaborative approach is required. 
Moreover, consolidate and consistent surveillance is warranted to identify new and re-
emerging infections90,290. 
 
To continue the battle against HIV/STIs epidemic, resources, regular HIV/STI testing, effective 
and availability of therapy, appropriate (biomedical) interventions, and the infrastructure and 
resources to provide implementation are needed for success. Clinicians, scientists, public health 
practitioners and social workers should work together to better understand the epidemiology 
of HIV/STIs and the priority populations, the performance and characteristics of diagnostic 
tests, the effective treatment for the infection, and promote and enhance high coverage of 
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